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Chapter 1: Catalytic Directing Groups for the Regioselective Hydroformylation of 
Allylic Alcohols.
1
 
 
I. Background 
Hydroformylation, discovered in 1938 by Otto Roelen,
2
 is an important industrial 
process for the synthesis of aldehyde products. It is used to prepare millions of tons of 
commodity products each year, including detergents and other specialty chemicals. For 
example, hydroformylation of propene leads to butanal, which can be hydrogenated to 
form butanol, a common organic solvent; alternatively, butanal can be elaborated to form 
a phthalate ester 1.1, which is generally used as a plasticizer (Scheme 1.1). 
Scheme 1.1: Examples of Hydroformylation Products. 
 
Hydroformylation is especially useful synthetically because it is an atom economical C-C 
bond forming reaction. The reaction entails the rhodium-catalyzed insertion of carbon 
monoxide and hydrogen gas across an olefin to form the homologated compound. During 
the transformation, two potential regioisomers can be formed: the linear and the branched 
(Scheme 1.2). Typically, the linear isomer is formed preferentially due to steric 
congestion at the metal center.  
                                                          
1
 The work presented in this chapter has been done in collaboration with Thomas Lightburn and Ka Cheng. 
2
 a) Roelen, O. U.S. Patent 2327066, 1943. b) Roelen, O. Chem. Abstr. 1944, 38, 5501.   
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Due to the regioselectivity challenges associated with hydroformylation, its use in 
organic synthesis has been limited. A great deal of effort has been spent to successfully  
Scheme 1.2: Rhodium-Catalyzed Hydroformylation of Terminal Olefins 
 
develop catalysts that are selective for the formation of the linear isomer.
3
 However, 
fewer solutions have been presented for the selective formation of the branched product. 
One method relies on the incorporation of an electron-withdrawing group into the olefin.
4
 
Substrate such as vinyl acetates, vinyl cyanide and vinyl sulfones show a strong 
preference for the branched isomer due to their stabilization of the formal negative charge 
developing during hydrometallation. Furthemore, when placed at the optimal distance 
from the metal, these groups can pre-coordinate to the catalyst and carry out the 
transformation through chelation control. For example, direction by an amide 
functionality has been proposed in the literature; the - unsaturated amide 1.2 was 
hydroformylated to form exclusively, after cyclization, the benzyl protected 
methyldihydropyridinone 1.4 (Scheme 1.3).
5
  
 
 
                                                          
3
 a) Casey, C. P.; Whiteker, G. T.; Melville, M. G.; Petrovich, L. M.; Gavey, J. A.; Powell, D. R. J. Am. Chem. 
Soc. 1992, 114, 5535. b) Cuny, G. D.; Buchwald, S. L. J. Am. Chem. Soc. 1993, 115, 2066.  
4
 a) Devon, T. J.; Phillips, G. W.; Puckette, T. A.; Stavinoha, J. L.; Vanderbilt, J. J. U.S. Patent 4,694,109, 
1987. b) Devon, T. J.; Phillips, G. W.; Puckette, T. A.; Stavinoha, J. L.; Vanderbilt, J. J. Chem. Abstr. 1988, 
108, 7890. c) Yamashita, H.; Roan, B. L.; Sakakura, T.; Tanaka, M. J. Mol. Catal. 1993, 81, 225. 
5
 Ojima, I.; Korda, A.; Shay, W. R. J. Org. Chem. 1991, 56, 2024. 
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Scheme 1.3: Amide-Directed Hydroformylation of a Terminal Olefin. 
 
A number of phosphorous derivatives have also been used as directing groups for 
branch-selective hydroformylation. The use of phosphorous functionalities is 
advantageous because they can act as formal ligands on the metal center, and they are 
known to be efficient hydroformylation ligands.
1
 For example, substrate 1.5 (Scheme 
1.4)
6
 can undergo hydroformylation in a regioselective fashion to form branched 
aldehyde 1.7 with a selectivity of >20:1 over the linear isomer. The origin of this 
regiochemical outcome is based on a transient 5-membered chelate 1.6 after coordination 
of the biaryl phosphine. Comparing this result to hex-1-ene, the latter is instead 
hydroformylated under the same conditions to give preferentially the linear aldehyde in a 
3:1 ratio. Limitations of the above method include harsh conditions for the removal of the 
biaryl phosphine group and formation of stoichiometric amounts of byproduct. 
Scheme 1.4: Phosphine-Directed Hydroformylation of a Terminal Olefin. 
 
Another phosphorous directing group that can be employed in hydroformylation 
is the ortho-diphenylphosphanylbenzoic acid 1.11 (o-DPPBA) (Scheme 1.5). Its utility 
                                                          
6
 Jackson, W. R.; Perlmutter P.; Suh, G.-H. Chem. Comm. 1987, 724. 
4 
 
was shown during the hydroformylation of 1,2-disubstituted unsymmetric alkenes, which 
usually show low regiochemical control.
7
 Subjecting a variety of allylic-o-DPPB esters 
(1.8) to hydroformylation afforded regioisomeric aldehyde 1.9 in good yields and 
regioselectivities (Scheme 1.5);
8
 additionally, the meta variant of DPPBA, which 
heralded the work presented in Scheme 1.5, proved to be effective in the course of the 
total synthesis of phylanthocin.
9
 An advantage of this directing group when compared to 
other phosphines is its ability to form an ester linkage, which allows for an easier 
introduction and removal from the product. However, like the biarylphosphine directing 
group in 1.5, the o-DPPBA auxiliary must be used in stoichiometric quantities and it must 
be removed after the reaction is complete if it is not a desired component of the final 
product. 
Scheme 1.5: Regioselective Hydroformylation of Allylic-o-DPPB esters. 
 
 
                                                          
7
 Breit, B. Acc. Chem. Res. 2003, 36, 264. 
8
 Breit, B.; Grunanger, C. U.; Abillard, O. Eur. J. Org. Chem. 2007, 2497. 
9
 Burke, S. D.; Cobb, J. E.; Takeuchi, K. J. Org. Chem. 1990, 55, 2138. 
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II. Application of Catalytic Directing Groups in Hydroformylation 
To overcome the limitations of using stoichiometric directing groups for the 
hydroformylation of olefins, the ideal solution would be the use of catalytic amounts of a 
directing group. In 2008, the Tan
10
 group and the Breit
11
 group simultaneously reported 
the use of two phosphorous-based catalyst-directing groups for the branch-selective 
hydroformylation of terminal and internal olefins. The success of this strategy was based 
on the ability of the ligands to bind the substrate in a covalent but reversible manner 
without changing the nature of the substrate. The Breit group developed catalytic 
directing groups in the form of phosphonites capable of transesterification, and their use 
was applied for the hydroformylation of homoallylic and bishomoallylic alcohols. For the 
same purpose, the Tan group instead designed a phosphine-based ligand (1.12) (Figure 
1.1) that is not limited only to alcohol functionalities but can also bind to substrates 
containing a diverse set of functional groups, thus making this catalytic directing group 
more broadly applicable to the hydroformylation process. 
Figure 1.1: Design of the Scaffolding Ligand. 
 
 
                                                          
10
 Lightburn, T. E.; Dombrowski, M. T.; Tan, K. L. J. Am. Chem. Soc. 2008, 130, 9210. 
11
 a) Grunanger, C. U; Breit, B. Angew. Chem. Int. Ed. 2008, 47, 7346. b) Smejkal, T.; Breit, B. Angew. Chem. 
Int. Ed. 2008, 47, 311. 
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Figure 1.2: General Catalytic Cycle for Scaffolding Catalysis. 
 
The phosphine-based ligand consists of an azaphosphole derivative prepared in 
three steps from commercially available N-methylaniline. It is characterized by two 
independent domains: 1) a substrate binding domain that contains an aniline nitrogen 
capable of inducing transacetalization with an alcohol substrate, and 2) a metal binding 
domain that contains an aryl phosphine. These structural specifications allow the ligand 
7 
 
to act as a molecular scaffold that brings the metal catalyst and the substrate into close 
proximity. This mode of catalysis, which we termed scaffolding catalysis, allows for both 
acceleration of the reaction as well as control of regiochemistry (Figure 1.2). 
The unique substrate binding domain in the form of an orthoformate offers the 
possibility of bonding to a variety of functionalities, such as alcohols and amine 
derivatives, which are useful and common groups in subsequent synthetic manipulations. 
As such, the application of a scaffolding ligand allowed the Tan group to successfully 
carry out the regioselective hydroformylation of homoallylic alcohols,
10
 sulfonamides,
12
 
and the enantio- and regioselective hydroformylation of PMP-protected amines;
13
 the 
methodology was also extended to the formation of quaternary carbon centers through 
hydroformylation,
14
 a transformation which was considered until recently a formidable 
challenge in organic synthesis.
15
  
 
III. Hydroformylation of Allylic Alcohols. 
 In our latest synthetic efforts, after reporting excellent regioselectivities in the 
hydroformylation of 1,1-disubstituted olefins furnishing quaternary aldehyde products 
(Scheme 1.6),
14
 we attempted the application of the catalytic system described above for 
the directed hydroformylation  of substrates such as 1,2-di- and trisubstituted olefins. To 
that end, a variety of allylic alcohol substrates could potentially lead to the formation of 
                                                          
12
 Worthy, A. D.; Gagnon, M. M.; Dombrowski, M. T.; Tan, K. L. Org. Lett. 2009, 11, 2764. 
13
 a) Worthy, A. D.; Joe, C. L.; Lightburn, T. E.; Tan, K. L. J. Am. Chem. Soc. 2010, 132, 14757. b) Joe, C. L.; 
Tan, K. L. J. Org. Chem. 2011, 76, 7590. 
14
 Sun, X.; Frimpong, K.; Tan, K. L. J. Am. Chem. Soc. 2010, 132, 11841. 
15
 Dong, V. M.; Yeung, C. S. Angew. Chem. Int. Ed. 2011, 50, 809. 
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-hydroxyaldehyde products; this transformation would provide an alternative 
disconnection to the formaldehyde aldol reaction (Scheme 1.7).  
Scheme 1.6: Synthesis of Quaternary Carbon Centers via Hydroformylation. 
 
Investigations began with cinnamyl alcohol, a commercially available allylic 
alcohol.  During the optimization of the reaction conditions, it was observed that not all 
the material after hydroformylation could be accounted for by NMR, which resulted in 
Scheme 1.7: Formaldehyde Aldol Reaction and Hydroformylation for the 
Formation of -Hydroxyaldehydes. 
 
decreased yields and inaccurate regioselectivities. Based on previous experience
14
 with 
the hydroformylation of 1,1-disubstituted olefins, it was found that dimer 1.15 formed 
during the reaction (Scheme 1.8). Fortunately, a simple Pinnick oxidation converted 
compound 1.15 to the -hydroxyacid 1.16. The use of triphenylphosphine for the 
hydroformylation of cinnamyl alcohol provided the undesired selectivity in favor of the 
lactone product 1.17 in a 12:88 ratio and 75% yield (Scheme 1.10). Such selectivity is  
9 
 
Scheme 1.8: Dimerization of the Aldehyde Product after Hydroformylation. 
 
in accordance with other reports of hydroformylation of cinnamyl alcohol yielding the 
aldehyde  to the aromatic ring;16 this is due to the fact that rhodium is inclined to form a 
-allyl complex with the aromatic ring (Scheme 1.9), thus yielding the branch aldehyde 
preferentially in the case of styrene-based substrates. Using ligand 1.12, Rh(acac)(CO)2, 
and catalytic amounts of p-TsOH, it was found that the regioselectivity of the reaction 
could be completely reversed in favor of 1.16 (Scheme 1.10).  
Scheme 1.9: Hydroformylation of Styrene. 
 
 
 
                                                          
16
 a) Nozaki, K.; Li, W.; Horiuchi, T.; Takaya, H. Tetrahedron Lett. 1997, 38, 4611. b) Watkins, A. L.; 
Hashiguchi, B. G.; Landis, C. R. Org. Lett. 2008, 10, 4553. c) McDonald, R. I; Wong, G. W.; Neupane, R. P.; 
Stahl, S. S.; Landis, C. R. J. Am. Chem. Soc. 2010, 132, 14027.  
10 
 
Scheme 1.10: Hydroformylation of Cinnamyl Alcohol. 
 
Table 1.1: Pressure Optimization. 
 
The optimal conditions for the cinnamyl alcohol substrate were found to be mild. 
Using 1% Rh(acac)(CO)2, 10% ligand 1.12, 0.05% p-TsOH, 45 
o
C and 100 psi, the 
expected  -hydroxy acid 1.16 was obtained, upon oxidation, in 83% yield  and excellent 
11 
 
regioselectivity (Table 1.1, entry 2).
17
 It was found that changing the CO/H2 pressure 
showed little effect on the conversion and selectivity. 
Given the excellent results obtained with the hydroformylation of cinnamyl 
alcohol, expansion of the substrate scope was investigated. Electronic perturbations and 
more sterically hindering groups on the aromatic ring afforded the desired products 
without erosion of regioselectivity (Table 1.2, entries 1-3). Both alkyl substituted E and Z 
olefins afforded the desired product with good yields and excellent regioselectivities 
(Table 1.2, entries 4-7). The reaction was also tolerant of heteroatoms in the form of a 
phthalamide and a TBDPS ether (Table 1.2, entries 8 and 9). Although phthalamide 
groups are known directing groups in hydroformylation,
18
 the use of catalytic quantities 
of ligand 1.12 allows for a complete reversal of the inherent regioselectivity of the 
substrate to afford the -aminoacid product. 
The application of ligand 1.12 also allows the use of mild conditions in the 
hydroformylation of trisubstituted olefins, a challenging substrate class. Because they are 
less reactive than 1,2-disubstituted olefins,
7
 the hydroformylation of trisubstituted olefins 
requires slightly more elevated temperatures in the presence of 20 mol % 1.12. For 
example, the hydroformylation of 1.34 was accomplished using 2 mol% Rh(acac)(CO)2, 
20% 1.12, at 55 
o
C and 50 psi to furnish the desired product in 85% yield (Scheme 1.11). 
Since the insertion of the rhodium hydride into the olefin occurs through a syn addition, 
hydroformylation of both E- and Z-3-methyloct-2-en-1-ol leads to the formation of single 
                                                          
17
 Lightburn, T. E.; De Paolis, O. A.; Cheng, K. H., Tan, K. L. Org. Lett. 2011, 13, 2686. 
18
 a) Zhang, X.; Cao, B.; Yu, S.; Zhang, X. Angew. Chem. Int. Ed. 2010, 35, 637. b) McDonald, R. I.; Wong, G. 
W.; Neupane, R. P.; Stahl, S. S.; Landis, C. R. J. Am. Chem. Soc. 2010, 132, 14027.  
12 
 
diastereomeric products (Scheme 1.11); the E olefin forms the anti product 1.37, while 
the Z olefin forms the syn product 1.39. 
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Table 1.2: Regioselective Hydroformylation of Allylic Alcohols. 
 
14 
 
Scheme 1.11: Hydroformylation of Trisubstituted Olefins. 
 
It was also shown that the hydroformylation products could be isolated in the 
aldehyde oxidation state. The reaction of cinnamyl alcohol and subsequent protection 
with pinacol affords the acetal in 86% yield (Scheme 1.12, equation 1), with selectivities 
comparable to those obtained after Pinnick oxidation. Acetal protection also allowed the 
successful hydroformylation of skip diene 1.41. Performing a Pinnick oxidation on the 
mixture directly after hydroformylation of 1.41 led to an unidentifiable mixture of 
products. It is likely that the unreacted distal olefin is sensitive to the oxidative 
conditions. Using acetal protection conditions, 1.42 can be isolated in an 84% yield 
(Scheme 1.12, equation 2). This procedure was also used in the hydroformylation of allyl 
15 
 
alcohol, which formed the desired product in 80% yield and good regioselectivity at 30
o
C 
(Scheme 1.12, equation 3). 
Scheme 1.12: Acetal Protection of Hydroformylation Products. 
 
16 
 
In order to showcase the practicality of the method, hydroformylation was 
performed on a larger scale. On 10 mmol scale, the product could be isolated in 83% 
yield with no erosion in regioselectivity (Scheme 1.12, equation 4). More importantly, the 
rhodium loading was reduced to 0.5 mol% and ligand loading was lowered to 5 mol%. 
The volume efficiency was also improved by increasing the concentration from 0.1M to 
0.5M.  
 
IV. Conclusion 
The design and synthesis of a phosphine ligand capable of acting as a scaffold for 
the rhodium catalyst and the olefin substrate has allowed for the resolution of a long-
standing problem in regioselective hydroformylation. The concepts of reversible covalent 
binding and intramolecular activation are at the heart of this new catalytic system and it 
has quickly become a powerful way of controlling regioselectivity. The hydroformylation 
of 1,2-di- and trisubstituted olefins can be carried out under mild conditions, and it 
generates, in the case of trisubstituted olefins, two stereocenters in a stereospecific 
fashion. The synthetic utility of the reaction was also extended by isolating the 
hydroformylation products in the aldehyde oxidation state, and by scaling up the reaction 
while reducing catalyst and ligand loading.  
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V. Experimental 
General Considerations 
Unless otherwise noted, all reagents were obtained from commercial suppliers and used 
without further purification.  Cinnamyl alcohol was purchased from Aldrich Chemical 
Co. and was dried in a vacuum dessicator with P2O5 before use.  Cis- and trans-2-hexen-
1-ol were purchased from Aldrich Chemical Co. and used as received.  3-Methyl-2-
buten-1-ol and allyl alcohol were purchased from Aldrich Chemical Co. and were 
distilled from CaSO4 and degassed by three successive freeze-pump-thaw cycles prior to 
being brought into a drybox for use.  Lithium reagents were titrated against N-benzyl 
benzamide in THF at 0 ∘C.  Flash column chromatography was performed using Silicycle 
SiliaFlash  F60 silica gel and ACS grade solvents as received from Fisher Scientific, 
except for methylene chloride which was distilled using a short path distillation head at 
ambient pressure (Note: methylene chloride as received contained a greasy yellow 
residue on evaporation).  All experiments were performed in oven- or flame-dried 
glassware under an atmosphere of nitrogen or argon using standard syringe and cannula 
techniques, except where otherwise noted.  All reactions were run with dry, degassed 
solvents dispensed from a Glass Contour Solvent Purification System (SG Water, USA 
LLC). 
 1
H and 
13
C NMR were performed on either a Bruker AS400 400 MHz or a Varian 
VNMRS 500 MHz instrument.  Deuterated solvents were purchased from Cambridge 
Isotope Labs and stored over 3Å molecular sieves.  All NMR chemical shifts are reported 
in ppm relative to residual solvent.  Coupling constants are reported in Hz.  All IR spectra 
were gathered on a Bruker Alpha FT-IR equipped with a single crystal diamond ATR 
18 
 
module and values are reported in cm
1
.  High resolution mass spectrometry (HRMS) 
data was generated in Boston College facilities with DART-TOF as the ionization 
technique. Hydroformylation was performed in an Argonaut Technologies Endeavor

 
Catalyst Screening System using 1:1 H2/CO supplied by Airgas, Inc.  Ligand 1.12 was 
prepared as previously reported by our group.
1
 
Substrate Syntheses and Characterizations 
The following compounds were made according to literature procedures and matched 
reported spectra: (E)-3-(4-methoxyphenyl)prop-2-en-1-ol,
2, 3 
(E)-3-cyclohexylprop-2-en-
1-ol,
4, 5
 (Z)-3-cyclohexylprop-2-en-1-ol,
4, 6
 (2E,5E)-hepta-2,5-dien-1-ol,
7
 (Z)-4-((tert-
butyldiphenylsilyl)oxy)but-2-en-1-ol,
8
 4,7-dihydro-1,3,2-dioxathiepine 2-oxide.
9
 
 
(E)-Methyl 3-(4-(trifluoromethyl)phenyl)acrylate. To a suspension of sodium hydride 
(310 mg, 12.6 mmol) in diethyl ether (40 mL) was added methyl-2-(diethoxyphosphoryl) 
acetate (2.3 mL, 12.6 mmol) in diethyl ether (8 mL) dropwise. After stirring for 1 h at 
room temperature, 4-(trifluoromethyl)benzaldehyde (1.6 mL, 11.5 mmol) in diethyl ether 
(2 mL) was added dropwise and the mixture was allowed to stir overnight. The resulting 
mixture was quenched with ammonium chloride, extracted with diethyl ether (3 x 30 mL) 
and dried over magnesium sulfate.  The crude product was purified on silica gel eluting 
with 10% ethyl acetate in hexanes to yield 680 mg (24%) of the title compound as a 
19 
 
white solid. 
1
H NMR (CDCl3, 500 MHz) δ 7.69 (d, 1H, J= 16), 7.65-7.60 (m, 4H), 6.50 
(d, 1H, J= 16), 3.82 (s, 3H); 
13
C NMR (CDCl3, 100 MHz) δ 166.7, 142.8, 137.7, 131.7 
(q, J= 32), 128.1, 126.1, 125.7 (q, J= 271), 120.3, 51.7; IR: 2956, 1711, 1318, 1111, 1066 
cm
-1
; HRMS Calcd. for C11H10F3O2 [M+H]
+
: 231.0633, Found: 231.0628. 
20 
 
 
 
 
 
21 
 
 
(E)-3-(4-(Trifluoromethyl)phenyl)prop-2-en-1-ol (1.20).  A suspension of lithium 
aluminum hydride (318 mg, 8.40 mmol) in diethyl ether (8 mL) was cooled to 0 C.  
Aluminum trichloride (511 mg, 2.80 mmol) in diethyl ether (4 mL) was added slowly.  
The mixture was allowed to warm to room temperature and was stirred for an additional 
30 min. (E)-methyl 3-(4-(trifluoromethyl)phenyl)acrylate (680 mg, 2.8 mmol) in diethyl 
ether (8 mL) was added dropwise and allowed to stir for 30 min.  The reaction mixture 
was quenched with 15% aqueous sodium hydroxide and then acidified with 1M 
hydrochloric acid. The aqueous layer was extracted with diethyl ether (3 x 20 mL), 
washed with brine and dried over magnesium sulfate. The crude product was purified on 
silica gel eluting with 20% ethyl acetate in hexanes to yield 420 mg (70 %) of the title 
compound as a white solid. 
1
H NMR (CDCl3, 400 MHz) δ 7.55 (d, 2H, J= 8.2), 7.46 (d, 
2H, J= 8.2), 6.65 (d, 1H, J= 16), 6.44 (dt, 1H, J=16.0, 5.4), 4.35 (d, 2H, J= 5.4); 
13
C 
NMR (CDCl3, 100 MHz) δ 140.2, 131.2, 129.4 (q, J= 32.7), 129.2, 126.5, 125.5 (q, J= 
3.8), 124.1 (q, J= 271), 63.2; IR: 2374, 2937, 1337, 1123, 856 cm
-1
; HRMS Calcd. for 
C10H8F3 [M-H2O+H]
+
: 185.0578, Found: 185.0588. 
22 
 
 
 
 
 
 
23 
 
 
(E)-Methyl 3-(o-tolyl)acrylate.  To a suspension of sodium hydride (247 mg, 10.3 
mmol) in N,N-dimethylformamide (4.1 mL) at 0 C was added methyl 
diethylphosphonoacetate (1.89 mL, 10.3 mmol) dropwise.  The reaction was warmed to 
room temperature for 15 min and re-cooled to 0 C.  o-Tolualdehyde (1.35 g, 11.3 mmol) 
in N,N-dimethylformamide (3.6 mL) was added and the reaction was stirred for 20 h.  
The reaction was cooled to 0 C, quenched with water (200 mL), extracted with ethyl 
acetate (3 x 50 mL), dried over anhydrous magnesium sulfate and concentrated.  
Purification on silica gel eluting with 10% ethyl acetate in hexanes yielded 850 mg (43%) 
of a clear oil whose spectra matched those reported in the literature.
10
 
24 
 
 
 
(E)-3-(o-Tolyl)prop-2-en-1-ol (1.22).  A 25 mL flask was charged with lithium 
aluminum hydride (499 mg, 13.1 mmol) and diethyl ether (13 mL).  The suspension was 
cooled to 0C in an ice water bath and aluminum trichloride (561 mg, 4.2 mmol) was 
added and the reaction was stirred for 30 min.  (E)-methyl-3-(o-tolyl)acrylate (850 mg, 
4.80 mmol) was added as a solution in diethyl ether (13 mL) and the reaction was stirred 
for 30 min.  The reaction was carefully quenched with 1M NaOH and then acidified with 
1M HCl.  Brine was added and the aqueous layer extracted with diethyl ether (3 x 50 
mL).  The combined organic layers were dried over anhydrous magnesium sulfate and 
 
25 
 
concentrated.  Purification on silica gel eluting with 25% ethyl acetate in hexanes yielded 
317 mg (44%) of the title compound as a clear oil.  
1
H NMR (CDCl3, 400 MHz) δ 7.46-
7.40 (m, 1H), 7.18-7.11 (m, 3H), 6.82 (dt, 1H, J= 15.6, 1.6), 6.24 (dt, 1H, J= 15.6, 6.0), 
4.33 (dd, 2H, J= 5.6, 1.6), 2.34 (s, 3H); 
13
C NMR (CDCl3, 100 MHz) δ 135.7, 135.5, 
130.3, 129.8, 129.0, 127.6, 126.1, 125.7, 64.0, 19.8; IR: 3372 (br), 3021, 2924, 2861, 
1723, 1677, 1485, 1460, 968, 747 cm
-1
; HRMS Calcd. for C10H11 [M-H2O+H]
+
: 
131.0861, Found: 131.0859. 
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(Z)-2-(4-Hydroxybut-2-en-1-yl)isoindoline-1,3-dione (1.30).  To a 100 mL flask was 
added 4,7-dihydro-1,3,2-dioxathiepine 2-oxide
9
 (2.99 g, 22.3 mmol), dimethylformamide 
(12 mL), and potassium phthalamide (3.54 g, 19.1 mmol) and the suspension was heated 
to 100 C for 1 h.  The reaction was cooled and quenched by careful addition of water (32 
mL).  The aqueous phase was extracted with diethyl ether (3 x 50 mL) and the combined 
organics were washed with water.  Purification on silica gel eluting with 35% ethyl 
acetate in hexane afforded 2.06 g (42%) of the title compound as a white solid. 
1
H NMR 
(CDCl3, 400 MHz) δ 7.85-7.79 (m, 2H), 7.73-7.67 (m, 2H), 5.92-5.85 (m, 1H), 5.58-5.50 
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(m, 1H), 4.41-4.34 (m, 4H), 2.56 (t, 1H, J= 6.4); 
13
C NMR (CDCl3, 100 MHz) δ 168.1, 
134.1, 133.2, 132.0, 124.9, 123.4, 58.0, 34.4; IR: 3458 (br), 2922, 1770, 1706, 1393, 
1325, 716 cm
-1
; HRMS Calcd. for C12H12NO3 [M+H]
+
: 218.0817, Found: 218.0825. 
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Synthesis of Substrate 1.36 
______________________________________________________________________________ 
 
(E)-Ethyl 3-methyloct-2-enoate.  To a flame dried 250 mL flask was added zirconocene 
dichloride (584 mg, 2.00 mmol).  Methylene chloride (40 mL) and hexane (15 mL) were 
added and the reaction was cooled to -30 C.  Trimethyl aluminum (2.97 mL, 31.0 mmol) 
was added and the reaction was stirred at -30 C for 10 min.  Water (270 uL, 15.0 mmol) 
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was added dropwise and the reaction was stirred for 10 min.  Hept-1-yne (1.31 mL, 10.0 
mmol) was added as a solution in methylene chloride (15 mL) and the reaction was 
stirred for 15 min.  Ethyl chloroformate (1.15 mL, 12.0 mmol) was added and the 
reaction was stirred for 30 min. allowing the reaction to warm to -10 C.  The reaction 
was allowed to warm to room temperature and a saturated aqueous solution of potassium 
carbonate (3.1 mL) was added slowly.  The reaction was stirred for 15 min., anhydrous 
magnesium sulfate (6.0 g) was added and the solution was filtered.  The solid was rinsed 
with diethyl ether (30 mL).  The combined organic layers were concentrated and purified 
on silica gel eluting with a gradient of 2-10% ethyl acetate in hexanes, affording 760 mg 
(41%) of the title compound as a clear oil.
 1
H NMR (CDCl3, 400 MHz) δ 5.63 (s, 1H), 
4.12 (q, 2H, J= 7.4), 2.14-2.07 (m, 5H), 1.50-1.40 (m, 2H), 1.35-1.19 (m, 7H), 0.87 (t, 
3H, J= 7.1); 
13
C NMR (CDCl3, 100 MHz) δ 166.9, 160.3, 115.4, 59.4, 40.9, 31.3, 27.0, 
22.4, 18.7, 14.3, 13.9; IR: 2957, 2931, 2860, 1715, 1648, 1460, 1220, 1144, 1111, 1041, 
868 cm
-1
; HRMS Calcd. for C11H21O2 [M+H]
+
: 185.1542, Found: 185.1539. 
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(E)-3-Methyloct-2-en-1-ol (1.36).  To a dry 50 ml flask was added (E)-ethyl 3-
methyloct-2-enoate (760 mg, 4.12 mmol) in toluene (9 mL).  The solution was cooled to 
0 C and DIBAL-H (1.62 mL, 9.10 mmol) was added dropwise as a solution in toluene (4 
mL). The reaction was stirred overnight, allowing the reaction to warm to room 
temperature.  The reaction was poured onto aqueous HCl (1M, 20 mL).  The aqueous 
layer was extracted with ethyl acetate (3 x 50 mL), dried over anhydrous magnesium 
sulfate and purified on silica gel, eluting with a gradient of 10-20% ethyl acetate in 
hexanes, resulting in 469 mg (80%) of the title compound as a clear oil.
 1
H NMR (CDCl3, 
400 MHz) δ 5.42-5.35 (m, 1H), 4.16-4.10 (m, 2H), 1.98 (t, 2H, J= 7.6), 1.64 (s, 3H), 
1.44-1.12 (m, 7H), 0.87 (t, 3H, J= 7.1); 
13
C NMR (CDCl3, 100 MHz) δ 140.2, 123.0, 
59.4, 39.5, 31.5, 27.3, 22.5, 16.1, 14.0; IR: 3415 (br), 2957, 2926, 2858, 1669, 1458, 
1379, 998 cm
-1
; HRMS Calcd. for C9H17 [M-H2O+H]
+
: 125.1330, Found: 125.1330. 
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Synthesis of Substrate 1.38 
______________________________________________________________________________ 
 
(E)-Ethyl 2-methylhept-2-enoate.  In a drybox, (carbethoxyethylidene)-
triphenylphosphorane (5.0 g, 13.8 mmol) was weighed into a dry 250 mL flask.  The 
flask was brought out of the dry box and placed under a nitrogen atmosphere.  Methylene 
chloride (42 mL) was added and valeraldehyde (1.34 mL, 12.5 mmol) was added 
dropwise.  The solution was stirred at room temperature for 4 h.  The reaction was 
concentrate to a slurry on a rotary evaporator and diluted with diethyl ether (60 mL).  
This suspension was filtered through a pad of silica gel, the silica gel was rinsed with 
diethyl ether (30 mL), and the combined organic solutions were again concentrated to a 
slurry.  Again, diethyl ether was added (60 mL) and the suspension was filtered though a 
pad of silica gel, rinsing with diethyl ether (30 mL).  The solution was concentrated and 
purified on silica gel eluting with a gradient of 2-4% ethyl acetate in hexane, resulting in 
1.27 g (60%) of the title compound as a clear oil.
 1
H NMR (CDCl3, 400 MHz) δ 6.73 (dt, 
1H, J= 6.1, 1.4), 4.16 (q, 2H, J= 7.2), 2.18-2.10 (m, 2H), 1.81-1.78 (m, 3H), 1.44-1.22 
(m, 7H), 0.88 (t, 3H, J= 7.0); 
13
C NMR (CDCl3, 100 MHz) δ 168.3, 142.3, 127.6, 60.3, 
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30.7, 28.3, 22.4, 14.2, 13.8, 12.3; IR: 2958, 2930, 1708, 1650, 1260, 1142, 1095, 745  cm
-
1
; HRMS Calcd. for C10H19O2 [M+H]
+
: 171.1385, Found: 171.1394. 
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(E)-2-Methylhept-2-en-1-ol.  A solution of (E)-ethyl 2-methylhept-2-enoate (1.23 g, 
7.23 mmol) in diethyl ether (5 mL) was added to a suspension of lithium aluminum 
hydride (302 mg, 7.95 mmol) in diethyl ether (15 mL) at 0 C.  The reaction was allowed 
to warm to room temperature and was stirred overnight.  The reaction was quenched by 
careful addition of water.  10% aqueous sulfuric acid (10 mL) was added and the aqueous 
layer was extracted with diethyl ether (3 x 60 mL).  The combined organic layers were 
dried over anhydrous magnesium sulfate and concentrated.  The residue was purified on 
silica gel, eluting with a gradient of 10-15% ethyl acetate in hexane, resulting in 823 mg 
(89%) of the title compound as a clear oil.
 1
H NMR (CDCl3, 400 MHz) δ 5.42-5.36 (m, 
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1H), 3.97 (s, 2H), 2.05-1.97 (m, 2H), 1.64 (s, 3H), 1.38-1.22 (m, 5H), 0.87 (t, 3H, J= 
7.2); 
13
C NMR (CDCl3, 100 MHz) δ 134.5, 126.6, 69.0, 31.6, 27.2, 22.3, 13.9, 13.6; IR: 
3316 (br), 2957, 2924, 2858, 1457, 1378, 1011 cm
-1
; HRMS Calcd. for C8H15 [M-
H2O+H]
+
: 111.1174, Found: 111.1170. 
 
 
37 
 
 
 
(E)-2-Methylhept-2-enal.  A 100 mL flask with stir bar and 3Å mol. sieves was flame 
dried under vacuum and cooled under a nitrogen atmosphere.  N-Methylmorpholine-N-
oxide (66 mg, 0.19 mmol) was added, followed by methylene chloride (21 mL) and 
acetonitrile (2 mL). (E)-2-methylhept-2-en-1-ol (801 mg, 6.24 mmol) was added as a 
solution in methylene chloride (3 mL).  The reaction was stirred for 25 min. and 
tetrapropylammonium perruthenate (66 mg, 0.19 mmol) was added.  The reaction was 
stirred for 4 h and concentrated to a black slurry.  The crude mixture was suspended in 
ethyl acetate/hexanes (1:1) and filtered through a plug of silica gel.  The solution was 
concentrated by rotary evaporation with a 10 C water bath to yield 454 mg (58%) of the 
title compound and was used without further purification.
 1
H NMR (CDCl3, 400 MHz) δ 
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9.38 (s, 1H), 6.50-6.44 (m, 1H), 2.37-2.29 (m, 2H), 1.74-1.71 (m, 3H), 1.51-1.42 (m, 
2H), 1.41-1.31 (m, 2H), 0.91 (t, 3H, J= 7.2); 
13
C NMR (CDCl3, 100 MHz) δ 195.4, 
155.0, 139.3, 30.5, 28.7, 22.4, 13.8, 9.1; IR: 2958, 2931, 2862, 1687, 1644, 1280 cm
-1
; 
HRMS Calcd. for C8H15O2 [M+H]
+
: 127.1123, Found: 127.1119. 
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(E)-3-Methylocta-1,3-diene.  In a dry box a 100 mL flask was charged with methyl 
triphenylphosphonium bromide (1.38 g, 3.87 mmol) and potassium tert-butoxide (434 
mg, 3.87 mmol).  The flask was brought out of the dry box and placed under a nitrogen 
atmosphere.  The flask was cooled in an ice water bath and tetrahydrofuran (10 mL) was 
added.  The resulting yellow solution was stirred for 10 min. at which time the flask was 
allowed to warm to room temperature and the reaction was stirred for an additional 30 
min.  The reaction was re-cooled in an ice water bath and (E)-2-methylhept-2-enal (444 
mg, 3.52 mmol) was added dropwise as a solution in tetrahydrofuran (1 mL).  The 
reaction was stirred for 15 min., the cold bath was removed, and stirring continued for an 
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additional 2 hours.  The reaction was concentrated to a slurry on a rotary evaporator with 
a 10 C water bath.  Diethyl ether (50 mL) was added and the suspension was filtered 
through silica gel, rinsing with diethyl ether (25 mL).  The solution was again 
concentrated to a slurry in the same fashion and pentane (50 mL) was added.  This 
suspension was filtered through silica gel.  Careful concentration (rotary evaporation with 
a 10 C water bath) was followed by purification on silica gel using pentane as eluent, 
affording 225 mg (52%) of the title compound as a clear oil. 
1
H NMR (CDCl3, 400 MHz) 
δ 6.35 (dd, 1H, J= 17.4, 10.6), 5.50-5.44 (m, 1H), 5.30 (d, 1H, J= 17.4), 4.90 (d, 1H, J= 
10.6), 2.16-2.08 (m, 2H), 1.72 (s, 3H), 1.40-1.22 (m, 4H), 0.88 (t, 3H, J= 7.0); 
13
C NMR 
(CDCl3, 100 MHz) δ 141.6, 133.8, 133.5, 110.2, 31.6, 27.9, 22.4, 13.9, 11.6; IR: 2957, 
2927, 2859, 1680, 1459, 1379, 989, 891 cm
-1
; HRMS Calcd. for C9H17 [M+H]
+
: 
125.1330, Found: 125.1336. 
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(Z)-3-Methyloct-2-en-1-ol (1.38).  In a dry box bis(cyclooctadiene)nickel (0) (11.5 mg, 
0.042 mmol) and tricyclohexylphosphine (11.8 mg, 0.042 mmol) were added to a 25 mL 
flask.  Toluene (6 mL) and pinacolborane (226 mg, 1.76 mmol) were added, followed by 
(E)-3-methylocta-1,3-diene (208 mg, 1.68 mmol) as a solution in toluene (1 mL).  The 
reaction was brought out of the dry box and was stirred for 4 h under an atmosphere of 
argon.  The reaction was cooled in an ice water bath, tetrahydrofuran (7 mL) was added, 
followed by aqueous sodium hydroxide (3M, 2 mL) and cold 35% aqueous hydrogen 
peroxide (2 mL).  The reaction was stirred for 3 h while warming to room temperature 
with the warming of the ice water bath.  The reaction was re-cooled in an ice water bath 
and was quenched with careful addition of saturated aqueous sodium thiosulfate (2 mL) 
(Caution: Delayed exotherm!).  The reaction was diluted with water (10 mL) and the 
aqueous layer was extracted with ethyl acetate (3 x 30 mL).  The combined organics were 
dried over anhydrous magnesium sulfate and concentrated.  Purification on silica gel 
eluting with 10% ethyl acetate in hexane afforded 200 mg (84%) of the title compound as 
a clear oil.  
1
H NMR (CDCl3, 400 MHz) δ 5.42-5.36 (m, 1H), 4.14-4.08 (m, 2H), 2.07-
2.01 (m, 2H), 1.73-1.70 (m, 3H), 1.41-1.18 (m, 6H), 1.06 (br s, 1H), 0.87 (t, 3H, J= 7.0); 
13
C NMR (CDCl3, 100 MHz) δ 140.6, 123.9, 59.1, 31.8, 31.6, 27.9, 23.4, 22.5, 14.1; IR: 
3315, 2957, 2928, 2858, 1448, 1377, 999 cm
-1
; HRMS Calcd. for C9H17 [M-H2O+H]
+
: 
125.1330, Found: 125.1331. 
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Branch Selective Hydroformylation Using Ligand 1.12 
Hydroformylation General Procedure A.  An oven dried glass reaction vial containing 
substrate (0.60 mmol) was placed in the Endeavor.  The Endeavor was sealed and purged 
with nitrogen (4 x 100 psi).  In a dry box a solution of dicarbonylacetylacetonato rhodium 
(I)  (1 mol %, 1.5 mg, 0.006 mmol), ligand 1.12 (10 mol %, 17.1 mg, 0.06 mmol), a 
solution of anhydrous p-toluene sulfonic acid (0.05 mol %, 527 L, 5.69 x 10-4 M in 
benzene) and benzene (6 mL) were combined in a syringe.  This solution was taken out 
of the dry box and injected into the Endeavor.  The Endeavor was purged with nitrogen 
(1 x 100 psi), stirring was started at 250 rpm, and the Endeavor was heated to and held at 
45 C for 10 minutes.  Stirring was stopped, the Endeavor was charged with 100 psi 
H2/CO, stirring was re-initiated at 700 rpm, and the Endeavor was maintained at 45 C 
and 100 psi H2/CO for 16 h.  The Endeavor was vented to ambient pressure and cooled to 
ambient temperature. 
Hydroformylation General Procedure B. An oven dried glass reaction vial containing 
substrate (0.20 mmol) was placed in the Endeavor.  The Endeavor was sealed and purged 
with nitrogen (4 x 100 psi).  In a dry box a solution of dicarbonylacetylacetonato rhodium 
(I)  (1 mol %, 0.52 mg, 0.002 mmol), ligand 1.12 (10 mol %, 5.7 mg, 0.02 mmol), a 
solution of anhydrous p-toluene sulfonic acid (0.05 mol %, 175 L, 5.69 x 10-4 M in 
benzene) and benzene (2 mL) were combined in a syringe.  This solution was taken out 
of the dry box and injected into the Endeavor.  The Endeavor was purged with nitrogen 
(1 x 100 psi), stirring was started at 250 rpm, and the Endeavor was heated to and held at 
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45 C for 10 minutes.  Stirring was stopped, the Endeavor was charged with 100 psi 
H2/CO, stirring was re-initiated at 700 rpm, and the Endeavor was maintained at 45 C 
and 100 psi H2/CO for 16 h.  The Endeavor was vented to ambient pressure and cooled to 
ambient temperature. 
Hydroformylation General Procedure C.  An oven dried glass reaction vial containing 
substrate (0.60 mmol) was placed in the Endeavor.  The Endeavor was sealed and purged 
with nitrogen (4 x 100 psi).  In a dry box a solution of dicarbonylacetylacetonato rhodium 
(I)  (2 mol %, 3.0 mg, 0.012 mmol), ligand 1.12 (20 mol %, 34.2 mg, 0.12 mmol), a 
solution of anhydrous p-toluene sulfonic acid (0.02 mol %, 211 L, 5.69 x 10-4 M in 
benzene) and benzene (6 mL) were combined in a syringe.  This solution was taken out 
of the dry box and injected into the Endeavor.  The Endeavor was purged with nitrogen 
(1 x 100 psi), stirring was started at 250 rpm, and the Endeavor was heated to and held at 
55 C for 10 minutes.  Stirring was stopped, the Endeavor was charged with 50 psi 
H2/CO, stirring was re-initiated at 700 rpm, and the Endeavor was maintained at 55 C 
and 50 psi H2/CO for 16 h.  The Endeavor was vented to ambient pressure and cooled to 
ambient temperature. 
Hydroformylation General Procedure D.  An oven dried glass reaction vial containing 
substrate (0.20 mmol) was placed in the Endeavor.  The Endeavor was sealed and purged 
with nitrogen (4 x 100 psi).  In a dry box a solution of dicarbonylacetylacetonato rhodium 
(I)  (2 mol %, 1.5 mg, 0.004 mmol), ligand 1.12 (20 mol %, 11.4 mg, 0.04 mmol), a 
solution of anhydrous p-toluene sulfonic acid (0.02 mol %, 70 L, 5.69 x 10-4 M in 
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benzene) and benzene (2 mL) were combined in a syringe.  This solution was taken out 
of the dry box and injected into the Endeavor.  The Endeavor was purged with nitrogen 
(1 x 100 psi), stirring was started at 250 rpm, and the Endeavor was heated to and held at 
55 C for 10 minutes.  Stirring was stopped, the Endeavor was charged with 50 psi 
H2/CO, stirring was re-initiated at 700 rpm, and the Endeavor was maintained at 55 C 
and 50 psi H2/CO for 16 h.  The Endeavor was vented to ambient pressure and cooled to 
ambient temperature. 
Hydroformylation General Procedure E. An oven dried glass reaction vial containing 
substrate (0.60 mmol) was placed in the Endeavor.  The Endeavor was sealed and purged 
with nitrogen (4 x 100 psi).  In a dry box a solution of dicarbonylacetylacetonato rhodium 
(I)  (2 mol %, 3.1 mg, 0.012 mmol), triphenylphosphine (4 mol %, 6.3 mg, 0.024 mmol) 
and benzene (6 mL) were combined in a syringe.  This solution was taken out of the dry 
box and injected into the Endeavor.  The Endeavor was purged with nitrogen (1 x 100 
psi), stirring was started at 250 rpm, and the Endeavor was heated to and held at 45 C 
for 10 minutes.  Stirring was stopped, the Endeavor was charged with 100 psi H2/CO, 
stirring was re-initiated at 700 rpm, and the Endeavor was maintained at 45 C and 100 
psi H2/CO for 16 h.  The Endeavor was vented to ambient pressure and cooled to ambient 
temperature. 
Pinnick Oxidation General Procedures 
Pinnick Oxidation General Procedure F.  The crude hydroformylation reaction mixture 
was concentrated on a rotary evaporator in a glass scintillation vial, a magnetic stir bar 
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added, and tBuOH (3 mL), 2-methyl-2-butene (636 L, 6.0 mmol), and a solution of 
sodium phosphate (288 mg, 2.4 mmol) and sodium chlorite (tech. grade (80%), 272 mg, 
2.4 mmol) in water (3 mL) was added dropwise.  The reaction was stirred vigorously for 
6 hours.  Saturated aqueous sodium chloride (1 mL) and 1M aqueous hydrogen chloride 
(1 mL) were added and the aqueous layer was extracted with dichloromethane (5 x 20 
mL).  The combined organic layers were dried over anhydrous magnesium sulfate, 
filtered and concentrated. The residue was analyzed by NMR to determine the 
regioselectivity of the reaction.  Purification on silica gel (1-5% MeOH in CH2Cl2) 
afforded pure carboxylic acid products. 
Note: An impurity, presumably arising from the use of 2-methyl-2-butene as an HOCl 
scavenger, has a very similar polarity on silica gel as the desired carboxylic acid 
products.  This impurity is not seen when Pinnick Oxidation General Procedure G is 
followed. 
Pinnick Oxidation General Procedure G. The crude hydroformylation reaction mixture 
was concentrated on a rotary evaporator in a glass scintillation vial, a magnetic stir bar 
added, and acetonitrile (1.5 mL), water (1.5 mL), sodium phosphate (288 mg, 2.40 
mmol), and 35% aqueous H2O2 (240 L, 2.46 mmol) were added to the vial.  The 
reaction was cooled in a water bath to 10 C and a solution of sodium chlorite (tech. 
grade 80%, 272 mg, 2.4 mmol) in water (1.5 mL) was added dropwise.  The reaction was 
stirred for 3 hours, warming to room temperature with the water bath.  Sodium sulfite 
(spatula tip) was added to quench the reaction and 1M aqueous hydrogen chloride (6 mL) 
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was added.  The reaction was extracted with methylene chloride (5 x 20 mL), dried over 
anhydrous magnesium sulfate, filtered and concentrated.  The residue was analyzed by 
NMR spectroscopy to determine the regioselectivity of the reaction.  Purification on 
silica gel (1-5% MeOH in CH2Cl2) afforded pure carboxylic acid products. 
Pinacol Acetal Protection General Procedure 
Pinacol Acetal Protection General Procedure H.  The crude hydroformylation reaction 
mixture was transferred to a glass scintillation vial using 1 mL of benzene to rinse out the 
reaction vial.  Pinacol (300 mg, 2.50 mmol) and a catalytic amount of p-toluene sulfonic 
acid (~10 mg) were added and the vials were sealed with rubber septa and black electrical 
tape and placed under a nitrogen atmosphere.  The vials were placed on a sand bath at 80 
C and were stirred for 90 minutes.  The reactions were cooled, concentrated, and 
analyzed by NMR to determine the regioselectivity of the reaction.  Purification on silica 
gel eluting with a gradient of 5-20% ethyl acetate in hexane afforded pure acetal 
products. 
Product Syntheses and Characterization 
 
2-Benzyl-3-hydroxypropanoic acid (1.16).  Hydroformylation of cinnamyl alcohol was 
performed following General Procedure B and oxidation following General Procedure G.  
Analysis of the crude oxidation showed a regioselectivity of 95:5.  Purification on silica 
gel eluting with 1-5% methanol in methylene chloride afforded the title compound as a 
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white solid (29.8 mg, 83%).  
1
H NMR (CDCl3, 400 MHz) δ 7.32-7.17 (m, 5H), 3.81-3.67 
(m, 2H), 3.11-2.99 (m, 1H), 2.91-2.80 (m, 2H); 
13
C NMR (CDCl3, 100 MHz) δ 179.6, 
138.2, 128.9, 128.7, 126.6, 61.9, 48.8, 34.0; IR: 3061, 3028, 2945, 1709, 1244, 1199, 
1030, 742, 700 cm
-1
; HRMS Calcd. for C10H13O3 [M+H]
+
: 181.0865, Found: 181.0861. 
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3-Phenyldihydrofuran-2(3H)-one (1.17). Hydroformylation of cinnamyl alcohol was 
performed following General Procedure E and oxidation following General Procedure F 
afforded the title compound in sufficient quantity for analysis.  
1
H NMR (CDCl3, 400 
MHz) δ 7.39-7.33 (m, 2H), 7.32-7.26 (m, 3H), 4.47 (app dt, 1H, J= 8.9, 3.3), 4.34 (app 
dt, 1H, J= 8.9, 6.6), 3.80 (app t, 1H, J= 9.6), 2.76-2.38 (m, 1H), 2.49-2.38 (m, 1H); 
13
C 
NMR (CDCl3, 100 MHz) δ 177.3, 136.6, 128.9, 127.9, 127.6, 66.5, 45.5, 31.6; IR: 3063, 
3031, 2990, 2913, 2251, 1762, 1498, 1453, 1372, 1147, 1023, 908, 728, 696, 554 cm
-1
; 
HRMS Calcd. for C10H11O2 [M+H]
+
: 163.0759, Found: 163.0760. 
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3-Hydroxy-2-(4-methoxybenzyl)propanoic acid (1.19). Hydroformylation of (E)-3-(4-
methoxyphenyl)prop-2-en-1-ol was performed following General Procedure A [except 
pressure (50 psi) and acid loading (0.012 mol % p-TsOH)] and oxidation following 
General Procedure F.  Analysis of the crude oxidation showed a regioselectivity of  
>95:5.  Purification on silica gel eluting with 1-5% methanol in methylene chloride 
afforded the title compound (109 mg, 87%).  
1
H NMR (CDCl3, 500 MHz) δ 7.10 (d, 2H, 
J= 8.5), 6.81 (d, 2H, J= 8.5), 3.76 (s, 3H), 3.74-3.68 (m, 2H), 2.99-2.96 (m, 1H), 2.85-
2.75 (m, 2H); 
13
C NMR (CDCl3, 100 MHz) δ 179.7, 158.3, 130.1, 129.9, 113.9, 61.9, 
55.2, 49.0, 33.2; IR: 2933, 1706, 1512, 1244, 1030 cm
-1
; HRMS Calcd. for C11H15O4 
[M+H]
+
: 211.0970, Found: 211.0979. 
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3-(4-Methoxyphenyl)dihydrofuran-2(3H)-one. Hydroformylation of (E)-3-(4-
methoxyphenyl)prop-2-en-1-ol was performed following General Procedure E and 
oxidation following General Procedure F and afforded the title compound in sufficient 
quantity for analysis.  
1
H NMR (CDCl3, 500 MHz) δ 7.19 (d, 2H, J= 8.5), 6.88 (d, 2H, 
J= 8.5), 4.44 (dt, 1H, J= 9.0, 4.0), 4.31 (dt, 1H, J= 9.5, 6.5), 3.78 (s, 3H), 3.74 (app t, 
1H, J= 9.0), 2.70-2.64 (m, 1H), 2.43-2.35 (m, 1H); 
13
C NMR (CDCl3, 100 MHz) δ 177.7, 
159.0, 131.6, 128.9, 114.3, 66.4, 55.3, 44.7, 31.6; IR: 2917, 1764, 1513, 1242, 1149, 
1025 cm
-1
; HRMS Calcd. for C11H13O3 [M+H]
+
: 193.0865, Found: 193.0869. 
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3-Hydroxy-2-(4-(trifluoromethyl)benzyl)propanoic acid (1.21). Hydroformylation of 
(E)-3-(4-(trifluoromethyl)phenyl)prop-2-en-1-ol was performed following General 
Procedure B [except pressure (50 psi) and acid loading (0.012 mol % p-TsOH)] and 
oxidation following General Procedure G. Analysis of the crude oxidation showed a 
regioselectivity of  >95:5.  Purification on silica gel eluting with 1-5% methanol in 
methylene chloride afforded the title compound as a clear oil (30.7 mg, 62%).  
1
H NMR 
(CDCl3, 400 MHz) δ 7.54 (d, 2H, J= 8.0), 7.32 (d, 2H, J= 8.0), 3.81 (dd, 1H, J= 11.2, 
3.4), 3.70 (dd, 1H, J= 11.2, 6.4), 3.10 (dd, 1H, J= 13.4, 6.4), 2.98-2.82 (m, 2H); 
13
C 
NMR (CDCl3, 100 MHz) δ 178.5, 142.3, 129.2, 128.9 (q, J= 32.5), 125.5 (q, J= 3.7), 
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124.1 (q, J= 270), 61.7, 48.4, 33.6; IR:  2942, 1710, 1323, 1161, 1111, 1067, 1019 cm
-1
; 
HRMS Calcd. for C11H12F3O3 [M+H]
+
: 249.0738, Found: 249.0737. 
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3-(4-(Trifluoromethyl)phenyl)dihydrofuran-2(3H)-one. Hydroformylation of (E)-3-(4-
(trifluoromethyl)phenyl)prop-2-en-1-ol was performed following General Procedure E 
and oxidation following General Procedure F and afforded the title compound in 
sufficient quantity for analysis.  
1
H NMR (CDCl3, 500 MHz) δ 7.62 (d, 2H, J= 8.5), 7.42 
(d, 2H, J= 8.5), 4.49 (dt, 1H, J= 8.5, 2.5), 4.36 (dt, 1H, J= 9.5, 6.5), 3.87 (app t, 1H, J= 
9.0), 2.78-2.71 (m, 1H), 2.49-2.40 (m, 1H); 
13
C NMR (CDCl3, 100 MHz) δ 176.5, 140.5, 
130.0 (q, J= 32.5), 128.3, 125.8 (q, J= 3.7), 123.9 (q, J= 271), 66.5, 45.2, 31.3; IR: 2916, 
1768, 1324, 1159, 1114, 1067 cm
-1
; HRMS Calcd. for C11H10F3O2 [M+H]
+
: 231.0633, 
Found: 231.0642. 
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3-Hydroxy-2-(2-methylbenzyl)propanoic acid (1.23). Hydroformylation of (E)-3-(o-
tolyl)prop-2-en-1-ol was performed following General Procedure A [except pressure (50 
psi) and acid loading (0.012 mol % p-TsOH)] and oxidation following General Procedure 
F.  Analysis of the crude oxidation showed a regioselectivity of 94:6.  Purification on 
silica gel eluting with 1-5% methanol in methylene chloride afforded the title compound 
as a clear oil (108 mg, 93%).  
1
H NMR (CDCl3, 400 MHz) δ 7.19-7.13 (m, 4H), 3.86-
3.72 (m, 2H), 3.15-3.07 (m, 1H), 2.92-2.84 (m, 2H), 2.36 (s, 3H); 
13
C NMR (CDCl3, 100 
MHz) δ 179.6, 136.5, 136.3, 130.5, 129.6, 126.8, 126.0, 62.0, 47.7, 31.3, 19.3; IR: 3018, 
2948, 1704, 1459, 1408, 1382, 1242, 1185, 1026, 740 cm
-1
; HRMS Calcd. for C11H15O3 
[M+H]
+
: 195.1021, Found: 195.1027. 
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3-(o-Tolyl)dihydrofuran-2(3H)-one. Hydroformylation of (E)-3-(o-tolyl)prop-2-en-1-ol 
was performed following General Procedure E and oxidation following General 
Procedure F and afforded the title compound in sufficient quantity for analysis.  
1
H NMR 
(CDCl3, 400 MHz) δ 7.20-7.17 (m, 3H), 7.15-7.11 (m, 1H), 4.47 (app dt, 1H, J= 9.2, 
4.0), 4.36 (app dt, 1H, J=9.2, 7.0), 3.98 (app t, 1H, J= 9.2), 2.74-2.64 (m, 1H), 2.36-2.25 
(m, 4H); 
13
C NMR (CDCl3, 100 MHz) δ 177.7, 136.3, 135.5, 130.8, 127.6, 127.2, 126.6, 
66.5, 42.9, 31.1, 19.7; IR: 2980, 2913, 1766, 1494, 1461, 1372, 1152, 1025, 754 cm
-1
; 
HRMS Calcd. for C11H13O2 [M+H]
+
: 177.0916, Found: 177.0919. 
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2-(Hydroxymethyl)hexanoic acid (1.25). Hydroformylation of trans-2-hexen-1-ol was 
performed following General Procedure C [except pressure (50 psi) and acid loading 
(0.10 mol % p-TsOH)] and oxidation following General Procedure F.  Analysis of the 
crude oxidation showed a regioselectivity of >95:5.  Purification on silica gel eluting with 
1-5% methanol in methylene chloride afforded the title compound (71 mg, 81%). 
Hydroformylation of cis-2-hexen-1-ol was performed following General Procedure C 
[except pressure (50 psi) and acid loading (0.10 mol % p-TsOH)] and oxidation following 
General Procedure G.  Analysis of the crude oxidation showed a regioselectivity of  
>95:5.  Purification on silica gel eluting with 1-5% methanol in methylene chloride 
afforded the title compound (81 mg, 92%). 
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1
H NMR (CDCl3, 400 MHz) δ 3.79-3.73 (m, 2H), 2.61-2.56 (m, 1H), 1.67-1.62 (m, 2H), 
1.54-1.49 (m, 2H), 1.34-1.29 (m, 2H), 0.88 (t, 3H, J= 7.0); 
13
C NMR (CDCl3, 100 MHz) 
δ 180.3, 62.9, 47.4, 29.3, 27.9, 22.5, 13.8; IR: 3309 (br), 2956, 2931, 2862, 1704, 1189, 
1028, 625, 540 cm
-1
; HRMS Calcd. for C7H15O3 [M+H]
+
: 147.1021, Found: 147.1025. 
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3-Propyldihydrofuran-2(3H)-one. Hydroformylation of trans-2-hexen-1-ol was 
performed following General Procedure E and oxidation following General Procedure F 
and afforded the title compound in sufficient quantity for analysis.  
1
H NMR (CDCl3, 500 
MHz) δ 4.33 (app dt, 1H, J= 9.0, 3.0), 4.18 (app dt, 1H, J= 9.0, 7.0), 2.55-2.48 (m, 1H), 
2.41-2.35 (m, 1H), 1.97-1.90 (m, 1H), 1.88-1.82 (m, 1H), 1.47-1.38 (m, 3H), 0.95 (t, 3H, 
J= 7.5); 
13
C NMR (CDCl3, 100 MHz) δ 179.6, 66.4, 38.9, 32.4, 28.6, 20.5, 13.7; IR: 
2958, 1764, 1214, 1078, 865 cm
-1
; HRMS Calcd. for C7H13O2 [M+H]
+
: 129.0916, Found: 
129.0910. 
 
64 
 
 
 
 
 
 
 
65 
 
 
3-Cyclohexyl-2-(hydroxymethyl)propanoic acid (1.28). Hydroformylation of (E)-3-
cyclohexylprop-2-en-1-ol was performed following General Procedure A [except 
temperature (35 C), pressure (50 psi) and acid loading (0.025 mol % p-TsOH)] and 
oxidation following General Procedure F.  Analysis of the crude oxidation showed a 
regioselectivity of  >95:5.  Purification on silica gel eluting with 1-5% methanol in 
methylene chloride afforded the title compound as a clear oil (80.5 mg, 72%). 
Hydroformylation of (Z)-3-cyclohexylprop-2-en-1-ol was performed following General 
Procedure A [except pressure (50 psi) and acid loading (0.025 mol % p-TsOH)] and 
oxidation following General Procedure F. Analysis of the crude oxidation showed a 
regioselectivity of  >95:5.  Purification on silica gel eluting with 1-5% methanol in 
methylene chloride afforded the title compound as a clear oil (91.6 mg, 82%) 
1
H NMR (CDCl3, 400 MHz) δ 3.78-3.70 (m, 2H), 2.76-2.66 (m, 1H), 1.80-1.52 (m, 6H), 
1.38-1.06 (m, 5H), 0.95-0.81 (m, 2H); 
13
C NMR (CDCl3, 100 MHz) δ 181.0, 63.3, 44.8, 
35.7, 35.2, 33.2, 33.1, 26.4, 26.10, 26.08; IR: 2921, 2851, 1706, 1448, 1191, 1023, 906, 
732 cm
-1
; HRMS Calcd. for C10H19O3 [M+H]
+
: 187.1334, Found: 187.1333. 
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3-Cyclohexyldihydrofuran-2(3H)-one. Hydroformylation of (E)-3-cyclohexylprop-2-
en-1-ol was performed following General Procedure E and oxidation following General 
Procedure F and afforded the title compound in sufficient quantity for analysis.  
1
H NMR 
(CDCl3, 400 MHz) δ 4.27 (app dt, 1H, J= 8.8, 4.0), 4.20-4.12 (m, 1H), 2.49-2.41 (m, 
1H), 2.25-2.15 (m, 1H), 2.11-2.00 (m, 1H), 1.88-1.54 (m, 6H), 1.34-1.21 (m, 2H), 1.18-
1.01 (m, 3H); 
13
C NMR (CDCl3, 100 MHz) δ 178.8, 66.6, 56.5, 44.6, 37.9, 31.1, 28.6, 
26.2, 26.1, 24.7; IR: 2924, 2852, 1768, 1581, 1450, 1371, 1185, 1027 cm
-1
; HRMS 
Calcd. for C10H17O2 [M+H]
+
: 169.1228, Found: 169.1222. 
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4-(1,3-Dioxoisoindolin-2-yl)-2-(hydroxymethyl)butanoic acid (1.31). 
Hydroformylation of (Z)-2-(4-hydroxybut-2-en-1-yl)isoindoline-1,3-dione was performed 
following General Procedure A [except acid loading (0.025 mol % p-TsOH)] and 
oxidation following General Procedure F.  Analysis of the crude oxidation showed a 
regioselectivity of 88:12.  Purification on silica gel eluting with 1-5% methanol in 
methylene chloride afforded the title compound as a white solid (75.2 mg, 71%).  
1
H 
NMR (CD3OD, 400 MHz) δ 7.84-7.80 (m, 2H), 7.79-7.74 (m, 2H), 3.80-3.65 (m, 4H), 
2.56-2.48 (m, 1H), 2.09-1.98 (m, 1H), 1.93-1.83 (m, 1H); 
13
C NMR (CD3OD, 100 MHz) 
δ 175.8, 168.4, 133.9, 132.0, 122.6, 62.4, 45.8, 35.7, 26.8; IR: 3463, 3062, 1699, 1397, 
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1371, 1187, 908, 717, 529 cm
-1
; HRMS Calcd. for C13H14N1O5 [M+H]
+
: 264.0872, 
Found: 264.0878. 
 
 
 
 
70 
 
 
2-((2-Oxotetrahydrofuran-3-yl)methyl)isoindoline-1,3-dione. Hydroformylation of 
(Z)-2-(4-hydroxybut-2-en-1-yl)isoindoline-1,3-dione was performed following General 
Procedure E and oxidation following General Procedure F and afforded the title 
compound in sufficient quantity for analysis. (Note: Chromatography was not required; 
the title compound spontaneously crystallized out of methylene chloride solution and was 
filtered and rinsed with pentane yielding pure material.)  
1
H NMR (CDCl3, 400 MHz) δ 
7.84-7.80 (m, 2H), 7.79-7.74 (m, 2H), 3.78-3.65 (m, 4H), 2.55-2.48 (m, 1H), 2.08-1.98 
(m, 1H), 1.92-1.83 (m, 1H); 
13
C NMR (CD3OD, 100 MHz) δ 175.8, 168.4, 133.8, 132.0, 
122.6, 62.4, 45.8, 32.7, 26.8; IR: 3459 (br), 2946, 1699, 1398, 1188, 1039, 720 cm
-1
; 
HRMS Calcd. for C13H12NO4 [M+H]
+
: 246.0766, Found: 246.0765. 
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4-((tert-Butyldiphenylsilyl)oxy)-2-(hydroxymethyl)butanoic acid (1.33). 
Hydroformylation of (Z)-4-((tert-butyldiphenylsilyl)oxy)but-2-en-1-ol was performed 
following General Procedure A [except acid loading (0.20 mol % p-TsOH)] and 
oxidation following General Procedure F.  Analysis of the crude oxidation showed a 
regioselectivity of 85:15.  Purification on silica gel eluting with 1-5% methanol in 
methylene chloride afforded the title compound as a clear oil (187.9 mg, 84%).  
1
H NMR 
(CDCl3, 400 MHz) δ 7.68-7.63 (m, 4H), 7.45-7.34 (m, 6H), 3.58-3.54 (m, 4H), 2.58-2.56 
(m, 1H), 2.04-1.94 (m, 1H), 1.85-1.75 (m, 1H), 1.04 (s, 9H); 
13
C NMR (CDCl3, 100 
MHz) δ 180.0, 135.5, 133.1, 129.8, 127.8, 62.8, 61.8, 44.5, 30.9, 26.8, 19.1; IR: 3071, 
2956, 2857, 1708, 1427, 1107, 822, 737, 701, 613, 504 cm
-1
; HRMS Calcd. for 
C21H29O4Si [M+H]
+
: 373.1835, Found: 373.1845. 
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3-(((tert-Butyldiphenylsilyl)oxy)methyl)dihydrofuran-2(3H)-one. Hydroformylation 
of (Z)-4-((tert-butyldiphenylsilyl)oxy)but-2-en-1-ol was performed following General 
Procedure E and oxidation following General Procedure F and afforded the title 
compound in sufficient quantity for analysis.  
1
H NMR (CDCl3, 400 MHz) δ 7.67-7.76 
(m, 4H), 7.46-7.33 (m, 6H), 4.43-4.35 (m, 1H), 4.30-4.22 (m, 1H), 4.01 (dd, 1H, J= 10.0, 
4.6), 3.83 (dd, 1H, J= 10.0, 3.2), 2.74-2.66 (m, 1H), 2.41-2.31 (m, 2H), 1.03 (s, 9H); 
13
C 
NMR (CDCl3, 100 MHz) δ 177.9, 135.7, 135.5, 129.8, 127.8, 67.1, 62.8, 42.0, 29.7, 26.7, 
25.3; IR: 2931, 2857, 1773, 1428, 1111, 1024, 702, 504 cm
-1
; HRMS Calcd. for 
C21H30NO3Si [M+NH4]
+
: 372.1995, Found: 372.1988. 
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2-(Hydroxymethyl)-3-methylbutanoic acid (1.35).  Hydroformylation of 3-methyl-2-
buten-1-ol was performed following General Procedure C (except the substrate was 
included in the solution during preparation in a dry box) and oxidation following General 
Procedure G.  Purification on silica gel eluting with 1-5% methanol in methylene chloride 
afforded the title compound as a clear oil (68 mg, 85%).  Note:  Due to the water 
solubility of this compound, the oxidation reaction was quenched and acidified as noted 
in General Procedure G, and then concentrated to a slurry which was dissolved in 
methanol and dry loaded on silica gel prior to chromatography.  
1
H NMR (CDCl3, 400 
MHz) δ 3.86 (dd, 1H, J= 11.2, 8.8), 3.61 (dd, 1H, J= 11.2, 4.2), 2.41 (ddd, 1H, J= 8.8, 
7.2, 4.2), 2.08-1.95 (m, 1H), 0.98 (d, 3H, J= 6.8), 0.97 (d, 3H, J= 6.8); 
13
C NMR (CDCl3, 
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100 MHz) δ 180.0, 61.3, 54.0, 27.6, 20.5, 20.0; IR: 2963, 1705, 1467, 1392, 1269, 1195, 
1064, 1013, 830, 659 cm
-1
; HRMS Calcd. for C6H13O3 [M+H]
+
: 133.0865, Found: 
133.0860. 
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anti-2-(Hydroxymethyl)-3-methyloctanoic acid (1.37). Hydroformylation of (E)-3-
methyloct-2-en-1-ol was performed following General Procedure C and oxidation 
following General Procedure G.  Purification on silica gel eluting with 1-5% methanol in 
methylene chloride afforded the title compound as a clear oil (83.3 mg, 74%).  
1
H NMR 
(CDCl3, 400 MHz) δ 3.87 (dd, 1H, J= 11.2, 9.0), 3.73 (dd, 1H, J= 11.2, 3.8), 2.58-2.50 
(m, 1H), 1.98-1.86 (m, 1H), 1.42-1.14 (m, 9H), 0.91 (d, 3H, J= 6.8), 0.85 (t, 3H, J= 6.8); 
13
C NMR (CDCl3, 100 MHz) δ 180.4, 60.5, 52.5, 34.5, 32.7, 31.8, 26.7, 22.6, 16.6, 14.0; 
IR: 2957, 2927, 2857, 1707, 1461, 1381, 1188, 1035 cm
-1
; HRMS Calcd. for C10H21O3 
[M+H]
+
: 189.1491, Found: 189.1500. 
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syn-2-(Hydroxymethyl)-3-methyloctanoic acid (1.39). Hydroformylation of (Z)-3-
methyloct-2-en-1-ol was performed following General Procedure D and oxidation 
following General Procedure G.  Purification on silica gel eluting with 1-5% methanol in 
methylene chloride afforded the title compound as a clear oil (32.7 mg, 87%). 
1
H NMR 
(CDCl3, 400 MHz) δ 3.89 (dd, 1H, J= 11.0, 9.0), 3.72 (dd, 1H, J= 11.0, 3.9), 2.61-2.52 
(m, 1H), 1.91-1.79 (m, 1H), 1.48-1.10 (m, 9H), 0.94 (d, 3H, J= 6.8), 0.86 (t, 3H, J= 6.9); 
13
C NMR (CDCl3, 100 MHz) δ 180.1, 61.5, 52.6, 34.1, 32.6, 31.8, 26.6, 22.6, 17.1, 14.0; 
IR: 2957, 2927, 2858, 1704, 1461, 1383, 1189, 1015 cm
-1
; HRMS Calcd. for C10H21O3 
[M+H]
+
: 189.1491, Found: 189.1496. 
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3-Phenyl-2-(4,4,5,5-tetramethyl-1,3-dioxolan-2-yl)propan-1-ol (1.40). Hydroformyla-
tion of cinnamyl alcohol was performed following General Procedure A and pinacol 
protection following General Procedure H.  Analysis of the crude protection reaction 
showed a regioselectivity of 94:6.  Purification on silica gel eluting with 5-20% ethyl 
acetate afforded the title compound as a clear oil (137 mg, 86%).  
1
H NMR (CDCl3, 400 
MHz) δ 7.29-7.23 (m, 2H), 7.21-7.14 (m, 3H), 5.03 (d, 1H, J= 5.6), 3.66-3.50 (m, 2H), 
2.94-2.82 (m, 2H), 2.53-2.44 (m, 1H), 2.04-1.94 (m, 1H), 1.25 (s, 3H), 1.24 (s, 3H), 1.22 
(s, 6H); 
13
C NMR (CDCl3, 100 MHz) δ 139.6, 129.2, 128.3, 126.0, 102.9, 82.4, 81.8, 
61.6, 46.7, 32.8, 24.4, 24.3, 22.22, 22.17; IR: 3464, 2977, 2928, 1454, 1368, 1153, 1134, 
1082, 1030 cm
-1
; HRMS Calcd. for C16H25O3 [M+H]
+
: 265.1804, Found: 265.1804. 
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3-Phenyl-3-(4,4,5,5-tetramethyl-1,3-dioxolan-2-yl)propan-1-ol. Hydroformylation of 
cinnamyl alcohol following General Procedure E and pinacol protection following 
General Procedure H afforded the title compound in sufficient quantity for analysis.  
1
H 
NMR (CDCl3, 400 MHz) δ 7.30-7.25 (m, 2H), 7.23-7.17 (m, 3H), 5.14 (d, 1H, J= 5.6), 
3.66-3.57 (m, 1H), 3.56-3.46 (m, 1H), 2.90-2.83 (m, 1H), 2.19-2.08 (m, 1H), 1.96-1.83 
(m, 2H), 1.17 (s, 3H), 1.12 (s, 3H), 1.10 (s, 3H), 1.09 (s, 3H); 
13
C NMR (CDCl3, 100 
MHz) δ 140.6, 128.9, 128.2, 126.6, 103.0, 82.1, 81.8, 61.3, 48.8, 34.2, 24.1, 24.0, 22.3, 
22.1; IR: 3412, 2976, 2930, 2871, 1389, 1156, 1134, 1073, 700 cm
-1
; HRMS Calcd. for 
C16H25O3 [M+H]
+
: 265.1804, Found: 265.1810. 
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(E)-2-(4,4,5,5-Tetramethyl-1,3-dioxolan-2-yl)hept-5-en-1-ol (1.42). Hydroformylation 
of  (2E,5E)-hepta-2,5-dien-1-ol was performed following General Procedure B and 
pinacol protection following General Procedure H.  Purification on silica gel eluting with 
5-20% ethyl acetate afforded the title compound as a clear oil (122.2 mg, 84%).  
1
H NMR 
(CDCl3, 400 MHz) δ 5.44-5.29 (m, 2H), 4.91 (d, 1H, J= 6.0), 3.68-3.51 (m, 2H), 3.04 (br 
s, 1H), 2.12-1.91 (m, 2H), 1.72-1.63 (m, 1H), 1.58 (d, 3H, J= 4.8), 1.51-1.10 (m, 13H); 
13
C NMR (CDCl3, 100 MHz) δ 130.9, 125.2, 103.8, 82.1, 81.6, 62.4, 44.4, 30.0, 26.5, 
24.3, 24.1, 22.1, 22.0, 17.8; IR: 3454 (br), 2976, 2930, 1450, 1368, 1154, 964 cm
-1
; 
HRMS Calcd. for C14H27O3 [M+H]
+
: 243.1960, Found: 243.1963. 
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2-(4,4,5,5-Tetramethyl-1,3-dioxolan-2-yl)propan-1-ol (1.44). Hydroformylation of 
allyl alcohol was performed following General Procedure B [except temperature (30 C) 
and acid loading (0.10 mol % p-TsOH) and the substrate was included in the solution 
during preparation in a dry box)] and pinacol protection following General Procedure H 
[except pinacol (100 mg)].  Analysis of the crude protection reaction showed a 
regioselectivity of 87:13 as compared to the reported spectra of 3-(4,4,5,5-tetramethyl-
1,3-dioxolan-2-yl)propan-1-ol.
11
  Purification on silica gel eluting with 5-20% ethyl 
acetate afforded the title compound as a clear oil (30 mg, 80%).  
1
H NMR (CDCl3, 400 
MHz) δ 4.82 (d, 1H, J= 6.4), 3.59-3.44 (m, 2H), 2.99 (br s, 1H), 1.86-1.74 (m, 1H), 1,17 
(s, 12H), 0.87 (d, 3H, J= 7.2); 
13
C NMR (CDCl3, 100 MHz) δ 104.4, 82.2, 81.5, 65.0, 
40.6, 24.3, 23.9, 22.1, 21.9, 12.1; IR: 3462 (br), 2976, 2929, 2876, 1458, 1368, 1155, 
1104, 1038, 994, 978, 866 cm
-1
; HRMS Calcd. for C10H21O3 [M+H]
+
: 189.1491, Found: 
189.1497. 
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Diastereoselectivity in the Hydroformylation of Trisubstituted Olefins 
 
Hydroformylation, being a syn selective addition of hydrogen and carbon monoxide, is 
expected to give rise to anti-2-(hydroxymethyl)-3-methyloctanoic acid from (E)-3-
methylocta-1,3-diene and to syn-2-(hydroxymethyl)-3-methyloctanoic acid from (Z)-3-
methylocta-1,3-diene after oxidation of the aldehydes to the carboxylic acids.  The 
1
H 
and 
13
C NMR NMR spectra of the products gave rise to different signals, and a sample of 
a mixture of the two products (vide infra) confirms the presence of two distinct 
diastereomers as evidenced by the appearance of two separate doublets for the 3-methyl 
substituent in the 500 MHz 
1
H NMR spectrum.  
90 
 
 
500 MHz 
1
H NMR spectrum of a mixture of syn- and anti-2-(hydroxymethyl)-3-
methyloctanoic acid showing two doublets for the 3-methyl substituent, each arising from 
a separate diastereomer. 
Hydroformylation of 10 mmol of Cinnamyl Alcohol Using 5 mol % ligand 1.12 at 0.5 M 
 
Cinnamyl alcohol (1.34 g, 10.0 mmol) was equally divided between four oven-dried 
reaction vials and was loaded into the Endeavor. The Endeavor was sealed and purged 
with nitrogen (4 x 100 psi).  In a dry box dicarbonyl acetylacetonato rhodium (I) (0.5 mol 
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%, 12.9 mg, 0.05 mmol), ligand 1 (5.0 mol %, 142.7 mg, 0.5 mmol), and p-toluene 
sulfonic acid (0.003 mol %, 527 mL, 5.69 x 10
-4
 M in benzene) were diluted to a total 
volume of 4 mL in benzene.  1 mL of this solution was added to each of the four reaction 
vials via syringe and an additional 4 mL of benzene was added to each reaction vial via 
syringe. The Endeavor was purged with nitrogen (1 x 100 psi), stirring was started at 250 
rpm, and the Endeavor was heated to and held at 45 C for 10 minutes.  Stirring was 
stopped, the Endeavor was charged with 200 psi H2/CO, stirring was re-initiated at 700 
rpm, and the Endeavor was maintained at 45 C and 200 psi H2/CO for 16 h.  The 
Endeavor was vented to ambient pressure and cooled to ambient temperature.  The 
combined reaction solutions were transferred to a dry 250 mL flask and diluted with 
benzene (20 mL).  Pinacol (5.00 g, 42.3 mmol) and p-toluene sulfonic acid monohydrate 
(5.0 mol %, 95.0 mg, 0.50 mmol) were added.  The reaction was heated to 80 C in an oil 
bath and stirred for 90 minutes.  The reaction was concentrated by rotary evaporation and 
a crude NMR indicated a 95:5 regioselectivity.  Purification on silica gel eluting with a 
gradient of 5-10% ethyl acetate in hexanes afforded 2.162 g (83%) of the desired 
compound as a pale yellow oil. 
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Chapter 2: Scaffolding Catalysis as an Alternate and More Practical Solution to the 
Site-Selective Functionalization of 1,2-Diols. 
 
I. Background 
The power and potential of catalytic directing groups has been recently 
demonstrated in the metal-catalyzed hydroformylation of olefins
1
 and other 
transformations such as the ortho arylation of phenols
2
 and hydroacylation of aldehydes.
3
 
Their use can be further extended to address unsolved problems in organic synthesis, 
such as the selective functionalization of polyfunctional molecules in a site- and 
stereocontrolled manner.  
In the past twenty years, a great deal of progress has been made in the design of 
organocatalysts to mediate various bond-forming processes with effective conveyance of 
stereochemical information.
4
 However, reports of organocatalysts capable of derivatizing 
a particular functional group in the presence of similar functional groups is not as 
common.
5
 By looking at the features and merits of enzymatic catalysis when compared to 
small molecule organocatalysts, it becomes clear that enzymes are still superior species in 
site-selective catalysis. In fact, the site-selective functionalization of polyols in a 
nonenzymatic fashion is still an ongoing challenge in the synthesis of complex natural 
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products and their subsequent derivatization for the development of new pharmaceutical 
agents.
6
  
In the recent literature, however, there have been several examples that address 
the issue of site-selective functionalization of a highly oxygenated compound by using a 
small molecule catalyst that can in part mimic the behavior of an enzyme. Scott Miller
7
 
has shown that a protected carbohydrate monomer (glucosamine derivative 2.1) is 
preferentially acylated with great success at the hydroxyl group in the 4-position (2.2) 
rather than the 5-position (2.3) (Scheme 2.1).  
Scheme 2.1: Peptide-Based Regioselective Functionalization of a Glucosamine 
Derivative. 
 
The transformation was carried out by using the peptide-based catalyst 2.4, wherein the 
acetamide group of 2.1 can undergo hydrogen bonding with the catalyst; it is thought that 
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both selectivity and reactivity are in part due to these noncovalent interactions that help 
preorganize the activated complex.                                                                         
The above example shows a catalyst that is able to differentiate between hydroxyl sites of 
very similar reactivity; however, it is much more challenging to discriminate between 
sites of vast difference in reactivity as in the case of a primary versus a secondary 
alcohol.
8
 
 
II. Issues of Site-Selectivity in Natural Product Synthesis 
The importance of site differentiation can be further appreciated in natural product 
synthesis where protection of a secondary alcohol in the presence of a primary is not 
trivial. In a recent report,
9
 Yu and coworkers prepared naturally occurring bis-lactones, 
canadensolide and sporothriolide, which have fungicidal activities. During the synthesis, 
a butynoic acid is coupled with a monoprotected diol 2.6 to obtain allenoester 
intermediate 2.7, which is then deprotected to 2.8 for further elaboration to the target 
compound 2.10 (Scheme 2.2). The protection and deprotection required to mask the 
reactivity of a primary alcohol renders the sequence inefficient: it generates waste and 
increases costs in terms of resources and time. To avoid an unnecessary multistep 
manipulation, the development of a method for the site-selective delivery of an O-
functionalizing reagent would be valuable. The synthesis outlined above contains a total 
of five steps to 2.10, with two of those steps representing protecting group manipulations; 
                                                          
8
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in principle the synthetic steps can be reduced by 40% if 2.8 can be directly obtained 
from 2.5. 
Scheme 2.2: Short Synthesis of Canadensolide and Sporothriolide. 
 
A more recent example from the Hoveyda
10
 group, where they report a catalytic, 
Z-selective olefin cross-metathesis of terminal enol ethers, again illustrates the need for a 
proper site-selective functionalization of diols. The utility of this newly developed 
method was applied to the synthesis of a natural product: specifically, the assembly of a 
plasmalogen phospholipid 2.16 that acts as an antioxidant to protect endothelial cells. The 
synthesis is short, efficient and it is an improvement upon the only other synthesis 
available in the literature by Qin
11
 and coworkers. The route starts from the commercially 
available, THP-protected propargyl alcohol 2.11, which is elaborated in a few steps, one 
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Scheme 2.3: Synthesis of a Plasmalogen Phospholipid. 
 
of which being the Z-selective olefin cross metathesis, to enantiopure diol 2.12. The latter 
is then manipulated in three steps to 2.15 so that the secondary alcohol is functionalized 
and the primary alcohol remains free. A total of ten steps are required to arrive at the 
natural product, two of which are protecting group manipulations; the synthesis can be 
shortened further by 20% if the secondary alcohol could be acylated directly. 
 
III. Scaffolding Catalysis as a Solution to Site-Selectivity  
Based on the aforementioned notions and challenges, the development of a new 
class of catalysts to achieve site-selective modifications with electrophile transfer 
reactions is of great importance. Such catalysts would allow an increase in efficiency 
98 
 
during the process of functionalization in natural product synthesis and derivatization, 
which usually requires unnecessary protection and deprotection sequences to obtain a 
single product. 
To that end, the challenge synthetic chemists face when functionalizing a 
secondary alcohol over a vicinal primary is one of reactivity. Within the same compound, 
a primary alcohol is about two orders of magnitude more reactive than a secondary one. 
In order to reverse this natural trend and functionalize a secondary alcohol in a single step 
with high levels of selectivities (i.e. 90:10), it is necessary to have a catalyst that is able to 
meet an energetic demand of 4 kcal/mol. To put this energetic difference in context for 
enantioselective reactions, a 4 kcal/mol energy difference yields products in 99.8% ee. 
Since there are few catalysts that can meet this demand, synthetic routes that provide 
secondary alcohol functionalization rely on multistep processes. For example, a typical 
method for the secondary protection of a 1,2-diol relies on bis-protection followed by 
monodeprotection.
12
 In designing a catalyst that can meet these energetic demands and 
provide monoprotected diol 2.19 preferentially (Scheme 2.4), the question becomes: what 
are the qualities that a successful catalyst should have to fulfill this objective? 
A potential solution to the above problem is based on selective binding of the 
substrate before the functionalization step. We have designed 2.20 (Figure 2.1) as a 
catalyst that could bind alcohols through a reversible covalent bond; the application of 
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Scheme 2.4: Selective Protection of a 1,2-Diol. 
 
this concept proved to be successful during the development of a bifunctional 
azaphosphole ligand (1.12), which simultaneously binds a molecule of substrate and the 
metal center during the hydroformylation of olefins. Furthermore, 2.20 incorporates an 
imidazole group that can serve to activate electrophiles and deliver them in an 
intramolecular fashion to the substrate. An advantage of this strategy is that the catalyst 
more favorably binds to the more accessible alcohol. 
Figure 2.1: Catalyst Design. 
 
The extent to which preferential binding occurs, as well as the rate of 
functionalization, will dictate the overall selectivity of the transformation. Given a 
generic catalyst 2.21, under conditions where binding of the primary and secondary 
alcohol to 2.21 is in equilibrium (Curtin-Hammett conditions) (Scheme 2.5), the overall 
selectivity will be a composite of Keq and the rate of functionalization (k1 and k2). In this 
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case, binding favors the primary alcohol, which leads to the functionalized secondary 
alcohol. However, it is likely that k1 > k2 since complex 2.22 contains a more reactive 
primary hydroxyl.    
To suppress the catalyzed pathway originating from complex 2.22, binding 
selectivity can be combined with stereoselectivity in order to better control the outcome 
of the transformation. Stereoselectivity as a control element can be derived from the 
conformational restrictions imposed by the structure of the catalyst and by the rigid 
nature of the covalent bond between the substrate and catalyst. These parameters can then 
lead to a mismatched case when the secondary hydroxyl binds the catalyst, an effect that 
would decelerate the rate of functionalization to the undesired compound (i.e. slow k1). 
Alternatively, when the primary hydroxyl binds, a matched case places the free hydroxyl 
in the right position for functionalization, thus increasing the value of k2. At the end of 
the desired transformation, the bound product in complex 2.25 can be displaced by either 
methanol or another molecule of substrate to complete the catalytic cycle. 
A significant advantage gained from the basic design of 2.20 is the modular 
nature of its structure. The catalyst (2.28) is composed of 4 basic inputs: an aldehyde, a 
heterocycle, an aminoalcohol and an orthoformate/acetate. This modularity can help 
address and enhance binding selectivity and stereoselectivity as the control factors that 
affect overall site-selectivity before and during the functionalization process. To that end, 
the catalyst can be modified in order to change its activity, stability and selectivity. For 
example, different Lewis basic moieties can potentially be incorporated, such as pyridine. 
Different groups can be placed at the exchange site to make the substrate binding more 
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Scheme 2.5: Mechanism for Site-selectivity. 
 
selective. Alterations can be applied on the backbone that can make the catalyst more 
stable and rigidified to enforce a desired conformation. With these potential 
modifications, a large library of catalysts can be created from simple components.  
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Figure 2.2: Catalyst Library. 
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IV. Catalyst Synthesis 
Catalyst 2.21 is simple and inexpensive to make and it can be prepared in four 
steps with good overall yield (Scheme 2.6). The synthetic route starts with L-valine 
(2.29). Reduction of L-valine with lithiumaluminum hydride (LAH) under reflux 
conditions overnight affords L-valinol (2.30) in high yields and purity (98%). Compound 
2.31, L-valinol coupling partner, is made in 81% yield by deprotonation of N-
methylimidazole (NMI) with n-butyllithium and then trapping with dimethylformamide 
(DMF). Reductive amination between 2.30 and 2.31 forms aminoalcohol 2.32 in 60-70% 
yield. The last step of the catalyst synthesis is ring closure of aminoalcohol 2.32 with 
N,N-dimethylformamide dimethylacetal in methanol to obtain the the L-valine-based 
catalyst (2.21) in 48% yield after distillation. 
 
V. Exchange Studies with the Scaffolding Catalyst 
In order to develop a viable catalytic system, the exchange ability of the newly 
synthesized catalyst had to be determined. Initial studies commenced by investigating 
exchange between 2.21 and iPrOH. Under equilibrating conditions, the scaffolding 
catalyst exchanges with iPrOH with a Keq of 0.13, which indicates a binding affinity to 
methanol that is eight times higher when compared to a secondary alcohol. This result is  
similar to the one observed with phosphine 1.12 (Scheme 2.7). In contrast to phosphine 
1.12, which requires more than two hours to reach equilibrium at 45 
o
C, catalyst 2.21 
equilibrates in ten minutes at room temperature. This is likely due to the more electron-
donating aliphatic nitrogen atom as compared to the aniline nitrogen in the phosphine 
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Scheme 2.6: Catalyst Synthesis. 
 
ligand. Exchange occurs in the presence of the hydrochloride salt of diisopropylethyl 
amine (2.33) as the acid source; in the absence of an acid source equilibration is 
significantly slower (>72 hours). The difference in binding affinity between 2.21 and 
alcohols of different steric size, as it was observed above, would be crucial for the 
differentiation of hydroxyl sites in 1,2-diol substrates. Additionally the speed of exchange 
has to be high enough to outcompete any undirected pathway. 
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Scheme 2.7: Equilibration Abilities of 2.21 and Phosphine Ligand. 
 
 
VI. Preliminary Studies in the Development of an Effective Site-Selective 
Functionalization of 1,2-Diols. 
In initial studies using these scaffolding catalysts, 1-phenyl-1,2-ethanediol (2.34) 
was used as the nucleophile, in addition to a silyl reagent as the electrophile. Using tert-
butyldimethylsilyl chloride (TBSCl) as the electrophile and N-methylimidazole as the 
control catalyst, it is clear that there is a preference for the TBS group to be placed on a 
primary alcohol (>99%) rather than a more hindered secondary one (Scheme 2.8, eq. 1); 
the secondary-protected diol 2.36 is not detected by GC. Under similar reaction 
conditions, but using 2.21 in place of N-methylimidazole, the selectivity for the desired 
product was found to be 4% (Scheme 2.8, eq. 2). A possible rationale for the low levels 
of selectivity is that it is energetically difficult to overturn inherent preferences when 
using TBSCl as the electrophile. 
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Scheme 2.8: Silylation of 2.34 with TBSCl. 
 
With this data in hand, a smaller and less selective electrophile was screened, 
triethylsilyl chloride (TESCl). Carrying out a control experiment with NMI gave a 99:1 
selectivity in favor of the primary-protected diol 2.37 (Scheme 2.9, eq. 1). Though still 
highly favorable for primary protection under control conditions, this time the secondary-
protected product 2.38 was observed on GC. With 2.21, an 88:12 ratio was obtained 
(Scheme 2.9, eq. 2), which represents a ten-fold increase when compared to the 
undirected reaction. 
Based on the encouraging results outlined above, ways to diminish competing 
intermolecular background reactions promoted by the Lewis base functionality on the 
scaffolding catalyst were investigated. A way to address this problem is dilution of the 
reaction mixture. The original concentration of 0.2M (Table 2.1, entry 1) was decreased 
to 0.07M, which results in a two-fold increase in selectivity (Table 2.1, entry 2); any 
further dilution, however, does not lead to higher levels of selectivity (Table 2.1, entry 3).  
 
107 
 
Scheme 2.9: Silylation of 2.34 with TESCl. 
 
An additional solution to the problem is based on another important factor, which is the 
speed of binding between substrate and catalyst. It is crucial that the substrate exchanges 
onto the catalyst at a rate faster than the intermolecular transfer of the electrophile. 
Addition of a small amount of acid at the very beginning of the transformation increases 
the initial rate of exchange (Table 2.1, entry 4); in the absence of acid the exchange can 
be slow enough to be detrimental to the transformation. The combination of dilution and 
addition of acid leads to 33% selectivity for the secondary-protected product (Table 2.1, 
entry 5). An additional concern to be addressed was the possibility of bis-silylation of the 
desired product at the end of the directed transformation; some bis-silylation was indeed 
observed but it was only in very small quantities (<5%) in all cases.  
Using a chiral catalyst and substrate in the reaction could lead to a matched-
mismatched case, where the individual enantiomers of the substrate in the racemic form 
would behave differently. To test this, the individual enantiomers were synthesized from 
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enantiopure styrene oxide, obtained by hydrolytic kinetic resolution;
13
 once in hand, they 
were tested separately under the optimal conditions, giving rise to significant difference  
Table 2.1: Effects of Dilution and Acid Addition. 
 
in selectivities (Scheme 2.10): 10% of the desired compound was obtained with (S)-2.34 
and 41% was obtained with the (R)-2.34. An explanation for this outcome is that the 
binding selectivity, in the matched case, orients the substrate in such a way that allows 
for the free hydroxyl group to be in close proximity to the catalytic residue for effective 
intramolecular transfer during the functionalization step. Since the (R)-diol was the 
matched case, we used it as the substrate for most of the screening process.  
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Scheme 2.10: Selectivity of the Individual Enantiomers of 2.34. 
 
Among the variables to be considered in the screening process, the effects of 
catalyst 2.21 loading were tested. Changing the amount of catalyst does not have any 
impact on the selectivity of the reaction (Table 2.2). As low as 10% loading and as high 
as 50% loading does not lead to larger amounts of the desired product. It is highly likely 
that all background processes have been suppressed, and that the selectivity for this 
particular catalyst has reached a plateau under these conditions. 
Table 2.2: Effects of Catalyst Loading. 
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Table 2.3: Variation of the Aminoacid Backbone. 
 
Considering the fact that the L-valine-based catalyst might not be able to provide 
better selectivities than what was observed so far, other aminoacid-based derivatives were 
explored in the form of structure 2.39 (Table 2.3). The results did not display any 
definitive trends. The L-tertleucine-based catalyst (2.40) gave results similar to catalyst 
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2.21, with derivatives from L-alanine (2.42), L-leucine (2.41) and L-phenyl glycine (2.43) 
providing lower selectivities. The lower selectivity observed in the case of the L-phenyl 
glycine-based catalyst may arise from lowering of the basicity of the oxazolidine nitrogen 
which might not be as effective in promoting exchange. The unsubstituted version of the 
catalyst (2.20), which is the simplest catalyst derivative, was screened to no avail. 
Table 2.4: Structural Variation at the Position  to the Imidazole Ring. 
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Another important factor to consider is the fact that the catalysts form a mixture 
of diastereomers. It is possible that in these cases a particular diastereomer of the catalyst 
is more active and selective than the other, which could affect reactivity and selectivity.  
The work to fine-tune the structure of the catalyst moved on to the position  to 
the imidazole ring. Variation of the substitution pattern at that position could in principle 
allow the elevation of the matched-mismatched case observed earlier. The introduction of 
a new stereogenic center would provide a structure in the form of 2.44 (Table 2.4). 
Surprisingly, catalyst 2.48, prepared as a single diastereomer, provided high selectivity 
for the secondary protected product arising from (S)-2.34, whereas catalyst 2.21 was 
matched for (R)-2.34. These results are consistent with what was observed in the 
enantioselective desymmetrization of meso diols.
14
 In that case it was hypothesized that 
when the R alcohol of diol 2.49 binds to 2.48, the free hydroxyl is oriented toward the 
imidazole group, thus promoting functionalization (Scheme 2.11, eq. 1). Conversely, the 
S alcohol has the free hydroxyl placed away from the catalytic site, thereby preventing 
intramolecular processes. In the case of site-selectivity, the S alcohol of (S)-2.34 is well 
positioned for functionalization after binding of the primary hydroxyl (Scheme 2.11, eq. 
3), whereas the R alcohol of (R)-2.34 does not meet that requirement and instead allows 
intramolecular transfer onto the primary hydroxyl to become dominant (Scheme 2.11, eq. 
2). Other catalysts within this class were also prepared with high levels of 
diastereoselectivities (2.46 and 2.47), but their activity and selectivities were much lower 
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than expected. Future experimental efforts will focus on studying the exchange abilities 
of these catalysts and further screening of structural variations. 
Scheme 2.11: Matched-Mismatched Cases in Diol Functionalization 
 
Scheme 2.12: Control Reaction for Potential Intramolecular Silyl Transfer. 
 
Another concern to be considered was the possibility of silyl transfer from the 
secondary hydroxyl to the primary hydroxyl once the catalyzed reaction took place, thus 
leading to artificially lower selectivities. To confront that possibility, we carried out a 
control reaction (Scheme 2.12) in which we subjected the authentic product under similar 
reaction conditions in the presence of another 1,2-diol substrate (2.50) and catalyst 2.48; 
114 
 
to our delight, formation of compound 2.51 was not observed, ruling out silyl transfer as 
a cause for the observed background selectivity. 
 
VII. Desymmetrization of Glycerol through Scaffolding Catalysis. 
Glycerol represents an important building block found in a number of natural 
products (Figure 2.3), particularly as the backbone in lipids known as triglycerides. 
Compounds derived from glycerol are also found in specialty chemicals widely employed 
in the food, pharmaceutical and cosmetic industries.
15
 Among the derivatives of glycerol, 
many are prepared when the two enantiotopic primary hydroxyl groups are differentially 
functionalized. In their enantiomerically pure forms, such compounds are important 
synthetic intermediates to the extent that their preparation has become the focus of much 
attention in the past two decades. 
Figure 2.3: Representative Glycerol Derivatives. 
 
 In terms of catalysis, among several demonstrations for the desymmetrization of 
glycerol are based on enzymes such as lipases. Asano
15a
 and coworkers reported the 
esterification of glycerol in the presence of Chirazyme using both aromatic and aliphatic 
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 a) Batovska, D. I.; Tsubota, S.; Kato, Y.; Asano, Y.; Ubukata, M. Tetrahedron:Asymmetry 2004, 15, 3551. 
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anhydrides as the acyl donors (Scheme 2.13); unfortunately, poor yields and 
enantioselectivities were obtained from most of the substrates. 
Scheme 2.13: Enzymatic Desymmetrization of Glycerol 
 
Over the years a few nonenzymatic approaches to the enantioselective 
desymmetrization of glycerol have been reported in the literature. For example, a simple 
method to the enantioselective functionalization of glycerol is through a hydrolytic 
kinetic resolution of a racemic terminal epoxide bearing an ether functionality.
13
 The 
resolution is carried out by using a low loading (0.5 mol %) of a chiral (salen) Co
III
 
complex to provide a 47% yield and >99% ee of the desired compound (Scheme 2.14, eq. 
1). In a recent example, Miller and coworkers
16
 reported desymmetrization reactions of 
glycerol derivatives through asymmetric acylation (Scheme 2.14, eq. 2). The 
pentapeptide catalyst 2.52 was employed for the transformation and provided high levels 
of enantioselectivities (up to 97%) and moderate yields (up to 52%). The products 
obtained represent useful chiral building blocks that can be further elaborated to more 
complex structures of interest. 
Given the successful application of scaffolding catalysis to the enantioselective 
desymmetrization of meso diols carried out by our group,
14
 we thought possible that the 
application of the same approach could be useful in the enantioselective 
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 Lewis, C. A.; Sculimbrene, B. R.; Xu, Y.; Miller, S. J. Org. Lett. 2005, 7, 3021. 
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desymmetrization of meso polyols such as glycerol. The transformation can be carried 
out in the presence of a catalyst, with TBSCl as the electrophile of choice, for the 
asymmetric monoprotection of unsubstituted glycerol (2.53) in a single step (Scheme 
2.15). As previously observed in the site-selective functionalization of 1,2-diols, TBSCl 
is reluctant to be placed on a secondary hydroxyl group. Also, combined with the binding 
properties of a catalyst such as 2.20, we thought possible that TBSCl could be directed 
onto the primary hydroxyl in an asymmetric fashion.  
Scheme 2.14: Enantioselective Functionalization of Glycerol 
 
Scheme 2.15: Enantioselective Desymmetrization of Glycerol with TBSCl. 
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Preliminary studies for the above reaction relied on catalysts 2.21 and 2.48 to 
furnish the desired transformation. Under conditions very similar to the ones used in the 
enantioselective desymmetrization of meso diols, glycerol was initially treated with 10 
mol % of 2.21, in the presence of a catalytic amount of acid to facilitate exchange, 
followed by addition of TBSCl in acetonitrile; under these conditions, the product was 
formed as a racemic mixture (Table 2.5, entry 1). The same results were obtained when 
10 mol % of 2.48 was employed (Table 2.5, entry 2). By changing the solvent to THF, 
better enantioselectivities were observed; catalyst 2.21 afforded 22% ee (Table 2.5, entry 
3), while catalyst 2.48 afforded 34% ee (Table 2.5, entry 4). A significant amount of bis-
protected product is also obtained during functionalization, which accounts for about 
30% of converted starting material; it is possible that its formation is promoted through 
an undesirable background pathway.  
Table 2.5: Preliminary Catalyst Screening in the Enantioselective Desymmetrization 
of Glycerol. 
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Initial screening efforts focused on testing a variety of solvents, while using 2.48 
as the preferred catalyst, in order to suppress background reactions while improving 
yields and enantioselectivities of the desired product. To that end, reactions were run 
under more dilute conditions by changing the concentration from 0.2M to 0.07M; the 
amount of bis-protected product being formed was thus diminished to below 20% in all 
cases (Table 2.6). Among the solvents that were screened, tert-butanol furnished good 
yields and moderate enantioselectivity (Table 2.6, entry 4), while diethyl ether and 
methylene chloride appeared to be ineffective. Diethyl ether led to very poor yields  
Table 2.6: Effects of Solvent in the Enantioselective Desymmetrization of Glycerol 
 
(Table 2.6, entry 3), while methylene chloride led to very poor enantioselectivities (Table 
2.6, entry 1). Good yields and significantly improved enantioselectivities were observed 
when the reaction was carried out in EtOAc (Table 2.6, entry 5). The best yield and 
enantioselectivity were obtained when employing THF as the solvent (Table 2.6, entry 2), 
in the presence of 20 mol % of catalyst. Given these promising preliminary results, the 
119 
 
use of different catalyst structures and a more extensive fine-tuning of the reaction 
conditions in future screening efforts can lead to higher levels of yields and 
enantioselectivities. 
 
VIII. Conclusion 
The concepts of reversible covalent binding and intramolecular activation can be 
a powerful way of controlling regio- and enantioselectivities and allow for challenging 
transformations to be carried out under mild conditions.  
In terms of site-selectivity, to be able to overturn selectivity from 99:1 to almost 
1:1 (56:44) is a gain in energy of 2.7 kcal/mol, an impressive feat in itself. Rapid 
exchange and conformational restrictions are crucial aspects of a viable catalytic system; 
having that in mind, it is important to suppress the inherent background silylation caused 
by the catalyst itself through fine-tuning of the structure in order to meet those 
requirements. The reactivity of most catalysts that have been prepared so far is 
remarkable and a more extensive catalyst synthesis and design can be the solution to the 
problem. Further exploration of different classes of catalysts with a variety of electronic 
and steric perturbations can provide us with the necessary energy to completely overturn 
the natural selectivity. Also, besides silylating agents, different electrophiles such acyl 
chlorides or anhydrides and different diol substrates can be screened to expand the 
reaction scope. 
In terms of enantioselective desymmetrization, the selective monoprotection of 
glycerol in a nonenzymatic manner has been the subject of study for several years. There 
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are a few methods available for that purpose, but none of them can do so in a single step. 
Scaffolding catalysis has the potential to carry out such desymmetrization in a single 
operation, with preliminary studies showing levels of enantioselectivities as high as 80% 
ee and yields in the 60% range. Once the proper conditions to reach higher levels of 
enantioselectivity have been found, the desymmetrization process can be coupled with 
the selective functionalization of the secondary alcohol to provide an efficient method for 
the derivatization of glycerol to a variety of natural products. 
 
IX. Experimental 
General Considerations 
Unless otherwise noted, all reagents were obtained from commercial suppliers and used 
without further purification.  Lithium reagents were titrated against 2-pentanol using 
1,10-phenanthroline as the indicator.  Flash column chromatography was performed 
using EMD Silica Gel 60 (230-400 mesh) and ACS grade solvents as received from 
Fisher Scientific.  All experiments were performed in oven or flame dried glassware 
under an atmosphere of nitrogen or argon using standard syringe and cannula techniques, 
except where otherwise noted.  All reactions were run with dry, degassed solvents 
dispensed from a Glass Contour Solvent Purification System (SG Water, USA LLC). 
 1
H 
and 
13
C NMR were performed on either a Varian Gemini 400 MHz, Varian Gemini 500 
MHz or a Varian Unity Inova 500 MHz spectrometer.  Deuterated solvents were 
purchased from Cambridge Isotope Labs and stored over 3Å molecular sieves.  C6D6 was 
degassed by three successive freeze-pump-thaw cycles and stored over 3Å molecular 
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sieves in a dry box under a nitrogen atmosphere.  All NMR chemical shifts are reported 
in ppm relative to residual solvent for 
1
H and 
13
C NMR.  Coupling constants are reported 
in Hz.  All IR spectra were gathered on a Bruker Alpha FT-IR equipped with a single 
crystal diamond ATR module and values are reported in cm
1
. All GC analyses were 
performed on an Agilent Technologies 7890A GC System. HRMS data were generated in 
Boston College facilities with DART-TOF as the ionization technique.  Analytical chiral 
high-performance liquid chromatography (HPLC) was performed on a Shimadzu-LC-
2010A HT. 
Site-Selectivity General Procedure 
Site-Selectivity General Procedure A.  To an oven-dried glass reaction vial, a solution 
of 2.34 (27.6 mg, 0.20 mmol), catalyst (0.040 mmol, 20 mol %), and 2.33 (3.3 mg, 0.02 
mmol, 10 mol %) in anhydrous THF (1.0 mL) was added. The reaction was stirred at 
room temperature for 10 minutes. Diisopropylethylamine (42 L, 0.24 mmol) was added, 
followed by addition of triethylchlorosilane (33 L, 0.20 mmol). After stirring at room 
temperature for 12 hours, the reaction was quenched by addition of 
diisopropylethylamine (30 L) and methanol (5 L). The mixture was stirred at room 
temperature for 10 minutes and filtered through a Pasteur pipette packed with silica gel, 
followed by flush with EtOAc (10 mL). GC analysis determined the selectivitiy of the 
desired product. 
Site-Selectivity General Procedure B.  Identical to General Procedure A, with 
compound 2.33 being excluded. 
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Site-Selectivity General Procedure C.  Identical to General Procedure A, with 
compound 2.33 being excluded and with the concentration being decreased to either 
0.070 M or 0.035 M. 
Site-Selectivity General Procedure D.  Identical to General Procedure A, with the 
concentration changed to 0.07M. 
Site-Selectivity General Procedure E. To an oven-dried glass reaction vial, a solution of 
2.34 (27.6 mg, 0.20 mmol) and catalyst (20.0 mg, 0.040 mmol), in anhydrous THF (0.5 
mL) was added. The reaction was stirred at room temperature for 10 minutes. 
Diisopropylethylamine (42 L, 0.24 mmol) was added, followed by addition of a solution 
of tert-butylchlorodimethylsilane (30.0 mg, 0.20 mmol) in anhydrous THF (0.5 mL). 
After stirring at room temperature for 12 hours, the reaction was quenched by addition of 
diisopropylethylamine (30 L) and methanol (5 L). The mixture was stirred at room 
temperature for 10 minutes and filtered through a Pasteur pipette packed with silica gel, 
followed by flush with EtOAc (10 mL). GC analysis afforded the selectivitiy of the 
desired product.   
Glycerol Desymmetrization General Procedure 
Desymmetrization General Procedure A. In an oven-dried glass reaction vial, glycerol 
(18.4 mg, 0.20 mmol), catalyst (0.02 mmol, 10 mol %) and 2.33 (1.2 mg, 3 mol %) were 
combined together. The mixture was then dissolved in anhydrous solvent (0.5 mL) and 
the reaction was stirred at room temperature for 10 minutes. Diisopropylethylamine (42 
L, 0.24 mmol) was added, followed by addition of a solution of tert-
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butylchlorodimethylsilane (30.0 mg, 0.20 mmol) in anhydrous solvent (0.5 mL). After 
stirring at room temperature for 12 hours, the reaction was quenched by addition of 
diisopropylethylamine (30 L) and methanol (5 L). The mixture was stirred at room 
temperature for 10 minutes and filtered through a Pasteur pipette packed with silica gel, 
followed by flush with EtOAc (10 mL). The yield of the product was determined by 
NMR analysis of the crude mixture using 1,3,5-trimethoxybenzene (50 μL of 0.40M in 
EtOAc, 0.020 mmol) as the internal standard. The ee of the product was determined by 
chiral HPLC analysis of the 1-naphthylcarboxylate ester (obtained by acylation with 1-
naphthoyl chloride in CH2Cl2 in the presence of diisopropylethylamine). 
Desymmetrization General Procedure B. Identical to Desymmetrization General 
Procedure A, with the application of the following changes: compound 2.33 was replaced 
by 1,2,2,6,6-pentamethylpiperidine hydrochloride, diisopropylethylamine was replaced 
by 1,2,2,6,6-pentamethylpiperidine, catalyst loading was increased to 20 mol % and the 
concentration was decreased to 0.07M. 
GC and HPLC Analysis Methods 
GC Method. An Agilent Technologies 7890A GC System equipped with a 7683B Series 
Injector was used to introduce samples into a J&W Scientific column (HP-5, 30 m, 0.320 
mm ID, 0.25 m film). The GC was run at 100 oC for 80 minutes, and then the 
temperature was ramped 8 
o
C/min. to a final temperature of 180 
o
C. Compounds were 
detected by FID and data was analyzed with Agilent Technologies GC Chemstation 
software. Retention times are reported in minutes. 
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HPLC Method. A Shimadzu-LC-2010A HT HPLC System was used to introduce 
samples into a Chiralcel OD column (hexanes/iPrOH = 97/3, 1.0 mL/min, 230 nm).
3
 
Retention times are reported in minutes. 
Product Syntheses and Characterizations 
 
2-((tert-Butyldimethylsilyl)oxy)-1-phenylethanol (2.35). A 100 mL flask was charged 
with tert-butyldimethylsilyl chloride (545 mg, 3.62 mmol) in THF (18 mL). 
Diisopropylethylamine (0.630 mL, 3.62mmol), N-methylimidazole (58uL, 0.72 mmol) 
and 1-phenyl-1,2-ethanediol (500 mg, 3.62 mmol) in THF was slowly added as a 
mixture. The reaction was allowed to stir for 48 hours before quenching with MeOH. The 
resulting mixture was evaporated in vacuo and the crude product was purified on silica 
gel with 5% EtOAc in hexanes to yield 630 mg (69%) of the title compound as a clear 
oil.  
1
H NMR (CDCl3, 500 MHz) δ 7.39-7.28 (m, 5H), 4.77-4.74 (m, 1H), 3.78 (dd, 1H, 
J= 4.0, 10.0), 3.56 (dd, 1H, J= 8.5, 10.0), 3.00 (d, 1H, J= 2.0), 0.93 (s, 9H), 0.083 (s, 3H), 
0.077 (s, 3H); 
13
C NMR (CDCl3, 100 MHz) δ 140.3, 128.3, 127.7, 126.2, 74.4, 68.9, 
25.9, 18.3, -5.3, -5.4; IR: 3443, 3063, 2953, 2856, 1253, 1103, 833, 698 cm
-1
; HRMS 
Calcd. for C14H25O2Si [M-H]
+
: 253.1623, Found: 253.1617. GC Method: 76.2 min. 
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2,2,3,3,8,8,9,9-Octamethyl-5-phenyl-4,7-dioxa-3,8-disiladecane. A 100 mL flask was 
charged with tert-butyldimethylsilyl chloride (2.4 g, 15.9 mmol) in THF (18 mL). N-
methylimidazole (1.3 mL, 15.9 mmol) and 1-phenyl-1,2-ethanediol (1.0 g, 7.24 mmol) in 
THF was slowly added as a mixture. The reaction was allowed to stir for 48 hours before 
quenching with MeOH. The resulting mixture was evaporated in vacuo and the crude 
product was purified on silica gel with 2% EtOAc in hexanes to yield 1.3 g (49%) of the 
title compound as a clear oil.  
1
H NMR (CDCl3, 500 MHz) δ 7.38-7.26 (m, 5H), 4.73 (dd, 
1H, J= 5.5, 7.5), 3.70 (dd, 1H, J= 7.0, 10.5), 3.58 (dd, 1H, J= 5.0, 10.0), 0.92 (s, 9H), 
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0.89 (s, 9H), 0.10 (s, 3H), 0.001 (s, 3H), -0.012 (s, 3H), -0.016 (s, 3H); 
13
C NMR (CDCl3, 
100 MHz) δ 142.8, 127.9, 127.2, 126.5, 76.1, 70.1, 26.0, 25.9, 18.4, 18.3, -4.64, -4.75, -
5.38, -5.48; IR: 2954, 2928, 2856, 1471, 1253, 1095, 830, 774 cm
-1
; HRMS Calcd. for 
C20H42NO2Si2 [M+NH4]
+
: 384.2763, Found: 384.2754. GC Method: 91.7 min. 
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2-((tert-Butyldimethylsilyl)oxy)-2-phenylethanol (2.36). A 100 mL flask was charged 
with 2,2,3,3,8,8,9,9-octamethyl-5-phenyl-4,7-dioxa-3,8-disiladecane (1.3 g, 3.55 mmol) 
in ethanol (7 mL), followed by addition of PPTS (0.892g, 3.55 mmol). The reaction was 
allowed to stir for 13 hours before quenching with triethylamine. The crude mixture was 
evaporated in vacuo and the crude product was purified on silica gel eluting with 5% 
EtOAc in hexanes to yield 647 mg (72%) of the title compound as a colorless oil. 
1
H 
NMR (CDCl3, 500 MHz) δ 7.35-7.26 (m, 5H), 4.76 (dd, 1H, J= 4.5, 7.5), 3.60-3.57 (m, 
2H), 2.07 (dd, 1H, J= 5.0, 8.5), 0.91 (s, 9H), 0.068 (s, 3H), -0.094 (s, 3H); 
13
C NMR 
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(CDCl3, 100 MHz) δ 141.4, 128.3, 127.7, 126.3, 75.9, 68.9, 25.8, 25.6, 18.2, -4.53, -4.96; 
IR: 3433, 2953, 2856, 1252, 1098, 912, 776, 698 cm
-1
; HRMS Calcd. for C14H25O2Si 
[M+H]
+
: 253.1623, Found: 253.1620. GC Method: 61.3 min. 
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1-phenyl-2-((triethylsilyl)oxy)ethanol (2.37). A 100 mL flask was charged with 
triethylchlorosilane (1.09 g, 7.24 mmol) in THF (18 mL). N-methylimidazole (578uL, 7.24 
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mmol) and 1-phenyl-1,2-ethanediol (1.0 g, 7.24 mmol) in THF (18 mL) was slowly added as a 
mixture. The reaction was allowed to stir for 48 hours before quenching with MeOH. The 
resulting mixture was evaporated in vacuo and the crude product was purified on silica gel with 
2% EtOAc in hexanes to yield 898 mg (49%) of the title compound as a clear oil.  
1
H NMR 
(CDCl3, 500 MHz) δ 7.42-7.29 (m, 5H), 4.79-4.77 (m, 1H), 3.79 (dd, 1H, J= 3.5, 10.0), 3.59 (dd, 
1H, J= 9.0, 10.5), 3.17 (d, 1H, J= 2.0), 1.01 (t, 9H, J= 8.0), 0.66 (q, 6H, J= 8.0); 
13
C NMR 
(CDCl3, 100 MHz) δ 140.5, 128.3, 127.7, 126.2, 74.5, 68.7, 6.73, 4.42; IR: 3456, 2954, 2876, 
1454, 1104, 1005, 743, 699 cm
-1
; HRMS (DART-TOF) calcd. for C14H25O2Si [M+H]
+
: 253.1623, 
found: 253.1624. GC Method: 88.2 min. 
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3,3,8,8-Tetraethyl-5-phenyl-4,7-dioxa-3,8-disiladecane. A 100 mL flask was charged 
with triethylchlorosilane (2.4 g, 15.93 mmol) in THF (9 mL). N-methylimidazole (1.3 g, 
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15.93 mmol) and 1-phenyl-1,2-ethanediol (1.0 g, 7.24 mmol) in THF (9 mL) was slowly 
added as a mixture. The reaction was allowed to stir for 96 hours before quenching with 
MeOH. The resulting mixture was evaporated in vacuo and the crude product was 
purified on silica gel with 2% EtOAc in hexanes to yield 824 mg (31%) of the title 
compound as a clear oil.  
1
H NMR (CDCl3, 500 MHz) δ 7.39-7.26 (m, 5H), 4.75 (dd, 1H, 
J= 5.0, 7.0), 3.72 (dd, 1H, J= 7.0, 10.0), 3.60 (dd, 1H, 5.0, 10.0), 0.97-0.92 (m, 18H), 
0.65-0.55 (m, 12H); 
13
C NMR (CDCl3, 100 MHz) δ 142.9, 127.9, 127.2, 126.4, 75.9, 
69.6, 6.77, 6.72, 4.89, 4.40; IR: 2953, 2876, 1124, 1095, 1004, 723, 697 cm
-1
; HRMS 
Calcd. for C20H39O2Si2 [M+H]
+
: 367.2488, Found: 367.2495. GC Method: 98.4 min. 
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2-Phenyl-2-((triethylsilyl)oxy)ethanol (2.38). A 50 mL flask was charged with 3,3,8,8-
tetraethyl-5-phenyl-4,7-dioxa-3,8-disiladecane (0.83 g, 2.26 mmol) in ethanol (5 mL), 
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followed by addition of PPTS (0.57g, 2.26 mmol). The reaction was allowed to stir for 14 
hours before quenching with triethylamine. The crude mixture was evaporated in vacuo 
and the crude product was purified on silica gel eluting with 2% EtOAc in hexanes to 
yield 280 mg (49%) of the title compound as a clear oil.  
1
H NMR (CDCl3, 500 MHz) δ 
7.33-7.26 (m, 5H), 4.76 (dd, 1H, J= 4.5, 7.5), 3.60-3.57 (m, 2H), 2.12 (dd, 1H, J= 5.0, 
8.5), 0.89 (t, 9H, J= 8.5), 0.59 (q, 6H, J= 8.5); 
13
C NMR (CDCl3, 100 MHz) δ 141.5, 
128.2, 127.7, 126.2, 75.6, 68.9, 6.66, 4.77; IR: 3406, 2953, 2875, 1454, 1098, 1004, 725, 
698 cm
-1
; HRMS Calcd. for C14H25O2Si [M+H]
+
: 253.1623, Found: 253.1634. GC 
Method: 85.1 min. 
 
136 
 
 
 
 
3-((tert-Butyldimethylsilyl)oxy)propane-1,2-diol (2.53). A 100 mL flask was charged 
with glycerol (2.0 g, 21.7 mmol) in CH3CN (20 mL). Diisopropylethylamine (3.8 mL, 
21.7 mmol), N-methylimidazole (173 L, 2.17 mmol) and tert-butyldimethylsilyl 
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chloride (3.3 g, 21.7 mmol) in CH3CN (20 mL) was slowly added as a mixture. The 
reaction was allowed to stir for 48 hours before quenching with MeOH. The resulting 
mixture was evaporated in vacuo and the crude product was purified on silica gel with 
20% EtOAc in hexanes to yield 2.2 g (49%) of the title compound as a clear oil.  
1
H 
NMR (CDCl3, 500 MHz) δ 3.72-3.55 (m, 5H), 3.08 (d, 1H, J= 5.0), 2.94 (appt, 1H, J= 
5.0), 0.87 (s, 9H), 0.047 (s, 6H); 
13
C NMR (CDCl3, 100 MHz) δ 71.9, 64.6, 63.9, 25.8, 
18.2, -5.46, -5.48; IR: 3384, 2928, 2857, 1253, 832, 774 cm
-1
; HRMS Calcd. for 
C9H23O3Si [M+H]
+
: 207.1416, Found: 207.1426. 
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2,2,3,3,9,9,10,10-Octamethyl-4,8-dioxa-3,9-disilaundecan-6-ol (2.54). A 100 mL flask 
was charged with glycerol (2.0 g, 21.7 mmol) in CH3CN (20 mL). Diisopropylethylamine 
(3.8 mL, 21.7 mmol), N-methylimidazole (173 L, 2.17 mmol) and tert-
butyldimethylsilyl chloride (3.3 g, 21.7 mmol) in CH3CN (20 mL) was slowly added as a 
mixture. The reaction was allowed to stir for 48 hours before quenching with MeOH. The 
resulting mixture was evaporated in vacuo and the crude product was purified on silica 
gel with 20% EtOAc in hexanes to yield 2.2 g (32%) of the title compound as a clear oil.  
1
H NMR (CDCl3, 500 MHz) δ 3.64-3.60 (m, 5H), 2.50 (d, 1H, J= 5.5), 0.87 (s, 18H), 
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0.044 (s, 12H); 
13
C NMR (CDCl3, 100 MHz) δ 71.8, 63.4, 25.8, 25.6, 18.2, -5.44, -5.45; 
IR: 3490, 2953, 2857, 1463, 1252, 1091, 831, 773 cm
-1
; HRMS Calcd. for C15H37O3Si2 
[M+H]
+
: 321.2281, Found: 321.2283. 
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3-((tert-Butyldimethylsilyl)oxy)-2-hydroxypropyl 1-naphthoate. A 100 mL flask was 
charged with 3-((tert-butyldimethylsilyl)oxy)propane-1,2-diol (1.0 g, 4.84 mmol) in 
DCM (6 mL) and cooled down to 0 
o
C. Diisopropylethylamine (0.843 mL, 4.84 mmol) 
and  naphthoyl chloride (0.730 mL, 4.84 mmol) in DCM (6 mL) was slowly added as a 
mixture. The reaction was allowed to stir at ambient temperature for 18 hours before 
quenching with MeOH. The resulting mixture was evaporated in vacuo and the crude 
product was purified on silica gel with 10% EtOAc in hexanes to yield 1.06 g (61%) of 
the title compound as an orange oil.  
1
H NMR (CDCl3, 500 MHz) δ 8.94 (dd, 1H, J= 1.0, 
9.0), 8.21 (dd, 1H, J= 1.5, 7.0), 8.00 (appd, 1H, 8.0), 7.87-7.85 (m, 1H), 7.63-7.59 (m, 
1H), 7.54-7.46 (m, 2H), 4.53-4.46 (m, 2H), 4.10 (appq, 1H, J= 4.5), 3.82-3.74 (m, 2H), 
2.84 (bs, 1H), 0.93 (s, 9H), 0.11 (s, 6H); 
13
C NMR (CDCl3, 100 MHz) δ 167.6, 133.9, 
133.6, 131.4, 130.4, 128.6, 127.8, 126.9, 126.3, 125.8, 124.5, 70.2, 65.8, 63.9, 25.9, 18.3, 
-5.36, -5.37; IR: 3467, 2952, 2856, 1715, 1243, 1131, 835, 778 cm
-1
; HRMS Calcd. for 
C20H29O4Si [M+H]
+
: 361.1835, Found: 361.1839. HPLC Method: tR = 14.8 min, tR = 
17.9 min. 
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Catalyst Synthesis 
N-methyl-imidazole-2-carboxaldehyde
1 
was made following literature procedures and 
matched reported spectra. 
 
(S)-2-((1-Methyl-1H-imidazol-2-yl)methylamino)propan-1-ol.
2
 To a solution of N-
methyl-imidazole-2-carboxaldehyde (650 mg, 8.7 mmol) in methanol (17 mL) was added 
(S)-Alaninol (960 mg, 8.7 mmol) and 4Å molecular sieves (1.7 g). After refluxing for 24 
hours, the reaction was cooled to room temperature, and NaBH4 (340 mg, 8.7 mmol) was 
added. The reaction was stirred at room temperature for 2 hours, followed by quenching 
with dropwise addition of concentrated HCl (0.44 mL). The resulting mixture was further 
neutralized with Na2CO3 (1.4 g). The precipitated salts were filtered off, and the filtrate 
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was concentrated. Flash column chromatography (CH2Cl2:MeOH = 10:1) afforded pure 
product as a colorless oil (1.0 g, 70%). 
1
H NMR (CDCl3, 500 MHz) δ 6.865 (d, 1H, J = 
1.2), 6.777 (d, 1H, J = 1.2), 3.91 (d, 1H, J = 14.4), 3.76 (d, 1H, J = 14.4), 3.60 (s, 3H), 
3.53 (dd, 1H, J = 11.0, 3.9), 3.26-3.30 (m, 1H), 2.82 (qt, 1H, J = 10.3, 3.9), 1.04 (d, 3H, J 
= 6.4); 
13
C NMR (C6D6, 126 MHz) δ 147.0, 126.9, 121.2, 65.5, 54.9, 42.9, 32.7, 17.3; IR: 
3201, 2872, 1636, 1499, 1452, 1283, 1048, 736, 662 cm
–1
; HRMS Calcd. for C8H16N3O 
[M+H]
+
: 170.1293, Found: 170.1292. 
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(4S)-2-Methoxy-4-methyl-3-((1-methyl-1H-imidazol-2-yl)methyl)oxazolidine (2.42) 
(66:34 dr). To a solution of (S)-2-(((1-methyl-1H-imidazol-2-yl)methyl)amino)propan-1-
ol (1.0 g, 6.0 mmol) in anhydrous methanol (24 mL) under argon was added N,N-
dimethylformamide dimethyl acetal (0.80 mL, 6.0 mmol). The reaction was stirred at 
room temperature for 2 hours, and the solvent was removed under vacuum. The residue 
was redissolved in anhydrous methanol (24 mL), and the reaction was stirred at room 
temperature for another 2 hours, at which time 
1
H NMR analysis showed that all the 
substrate was consumed and product had formed. The solvent was removed under 
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vacuum. The flask was brought into a dry glove box under nitrogen atmosphere, and the 
residue was extracted with degassed pentane. The pentane was removed under vacuum, 
and Kugelrohr distillation (170 °C @ 0.05 mm Hg) afforded pure product as a colorless 
oil (330 mg, 26%). 
1
H NMR (C6D6, 500 MHz) δ 7.15 (s, 0.34H), 7.125 (d, 0.66H, J = 
0.1), 6.37 (s, 0.34H), 6.36 (s, 0.34H), 5.24 (s, 0.66H), 5.17 (s, 0.34H), 3.98 (t, 0.34H, J = 
7.3), 3.78 (t, 0.66H, J = 6.8), 3.68-3.72 (m, 2H), 3.36-3.43 (m, 0.66H), 3.32-3.34 (m, 
0.34H), 3.28 (s, 0.66H), 3.23 (s, 0.66H), 3.14 (s, 0.34H), 3.07 (s, 0.34H), 2.94-2.96 (m, 
1H), 0.735 (d, 1H, J = 6.1), 0.705 (d, 2H, J = 5.9); 
13
C NMR (C6D6, 126 MHz) δ 145.7, 
145.4, 121.8, 121.7, 114.7, 111.7, 109.0, 73.1, 72.6, 57.9, 54.9, 53.1, 51.4, 47.1, 43.4, 
38.3, 32.7, 17.5, 16.8; IR: 2928, 1501, 1458, 1284, 1162, 1113, 1066, 1017, 975, 742 cm
–
1
; HRMS Calcd. for C19H14N3O [M-OMe]: 180.1137, Found: 180.1142. 
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(S)-3-Methyl-2-((1-methyl-1H-imidazol-2-yl)methylamino)butan-1-ol (2.32).
2
 To a 
solution of N-methyl-imidazole-2-carboxaldehyde (2.1 g, 20 mmol) in methanol (40 mL) 
was added (S)-Valinol (2.2 g, 20 mmol) and 4Å molecular sieves (4.0 g). After refluxing 
for 24 hours, the reaction was cooled to room temperature, and NaBH4 (760 mg, 20 
mmol) was added. The reaction was stirred at room temperature for 2 hours, followed by 
quenching with dropwise addition of concentrated HCl (1.0 mL). The resulting mixture 
was further neutralized with Na2CO3 (3.3 g). The precipitated salts were filtered off, and 
the filtrate was concentrated. Flash column chromatography (CH2Cl2:MeOH = 10:1) 
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afforded the pure product as a colorless oil (2.3 g, 58%). 
1
H NMR (CDCl3, 500 MHz)  
6.86 (d, 1H, J = 1.5), 6.77 (d, 1H, J = 1.2), 3.90 (d, 1H, J = 14.7), 3.78 (d, 1H, J = 14.9), 
3.62 (dd, 1H, J = 11.2, 3.7), 3.58 (s, 3H), 3.39 (dd, 1H, J = 11.0, 7.3), 2.42 (m, 1H), 1.74 
(m, 1H), 0.92 (d, 3H, J = 6.8), 0.87 (d, 3H, J = 6.8);
 13
C NMR (CDCl3, 125 MHz)  
147.4, 126.9, 121.3, 65.1, 61.6, 44.0, 32.6, 30.0, 19.5, 19.0; IR: 3199, 2955, 2871, 1500, 
1465, 1283, 1043, 734, 705, 661 cm
–1
; HRMS Calcd. for C10H20N3O [M+H]
+
: 198.1606, 
Found:198.1606. 
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(4S)-4-Isopropyl-2-methoxy-3-((1-methyl-1H-imidazol-2-yl)methyl)oxazolidine 
(2.21) (70:30 dr). To a solution of (S)-3-methyl-2-(((1-methyl-1H-imidazol-2-
yl)methyl)amino)butan-1-ol (860 mg, 4.4 mmol) in anhydrous methanol (18 mL) under 
argon was added N,N-dimethylformamide dimethyl acetal (580 L, 4.4 mmol). The 
reaction was stirred at room temperature for 2 hours, and the solvent was removed under 
vacuum. The residue was redissolved in anhydrous methanol (18 mL), and the reaction 
was further stirred at room temperature for 2 more hours until 
1
H NMR analysis showed 
that all of the substrate was consumed and product had formed. The solvent was removed 
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under vacuum. The flask was brought into a dry glove box under nitrogen atmosphere, 
and the residue was extracted with degassed pentane. The pentane was removed under 
vacuum, and Kugelrohr distillation (130 °C @ 0.05 mm Hg) afforded pure product as 
colorless oil (490 mg, 47%). 
1
H NMR (C6D6, 500 MHz) δ 7.15 (d, 0.3H, J = 1.2), 7.12 (d, 
0.7H, J = 1.0), 6.36 (d, 0.3H, J = 1.0), 6.35 (d, 0.7H, J = 1.2), 5.34 (s, 0.3H), 5.21 (s, 
0.7H), 4.02 (d, 0.3H, J = 13.9), 3.895 (t, 0.6H, J = 8.1), 3.84 (d, 0.3H, J = 13.9), 3.79 (t, 
0.7H), 3.74 (d, 0.7H, J = 13.4), 3.67-3.70 (m, 0.7H), 3.65 (d, 0.7H, J = 13.7), 3.17 (s, 
0.9H), 3.09 (s, 2.1H), 3.07 (s, 2.1H), 2.98 (s, 09H), 2.82-2.86 (m, 1H), 1.67 (dt, 0.7H, J = 
20.5, 6.8), 1.58 (ddd, 0.3H, J = 13.9, 6.8, 3.7), 0.715 (d, 0.3H, J = 6.8), 0.685 (d, 0.7H, J 
= 6.8), 0.645 (d, 0.7H, J = 6.8), 0.58 (d, 0.3H, J = 7.1); 
13
C NMR (CDCl3, 126 MHz) δ 
145.9, 145.5, 128.7, 128.2, 121.6, 121.3, 115.1, 111.9, 68.3, 67.1, 65.6, 64.7, 53.0, 51.8, 
49.3, 43.9, 32.5, 32.4, 30.7, 28.7, 20.1, 19.9, 17.5, 15.4; IR: 2956, 1500, 1466, 1284, 
1158, 1123, 1080, 1062, 986, 741 cm
–1
; HRMS Calcd. for C11H18N3O [M-OMe]: 
208.1450, Found: 208.1459. 
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(S)-3,3-Dimethyl-2-((1-methyl-1H-imidazol-2-yl)methylamino)butan-1-ol.
2
 To a 
solution of N-methyl-imidazole-2-carboxaldehyde (750 mg, 6.8 mmol) in methanol (14 
mL) was added (S)-tert-Leucinol (0.80 g, 6.8 mmol) and 4Å molecular sieves (1.4 g). 
After refluxing for 24 hours, the reaction was cooled to room temperature, and NaBH4 
(260 mg, 6.8 mmol) was added. The reaction was stirred at room temperature for 2 hours, 
followed by quenching with dropwise addition of concentrated HCl (0.34 mL). The 
resulting mixture was further neutralized with Na2CO3 (1.1 g). The precipitated salts were 
filtered off, and the filtrate was concentrated. Flash column chromatography 
(CH2Cl2:MeOH = 10:1) afforded the pure product as a colorless oil (720 mg, 50%). 
1
H 
NMR (CDCl3, 500 MHz)  6.97 (d, 1H, J = 1.5), 6.88 (d, 1H, J = 1.0), 4.20 (br s, 2H), 
4.15 (d, 1H, J = 15.9), 3.97 (d, 1H, J = 15.6), 3.82 (dd, 1H, J = 11.2, 3.7), 3.45 (s, 3H), 
3.51 (dd, 1H, J = 11.2, 8.1), 2.45 (dd, 1H, J = 8.1, 3.7), 0.94 (s, 9H);
 13
C NMR (CDCl3, 
125 MHz)  147.7, 126.0, 121.6, 68.7, 62.1, 46.0, 35.1, 32.9, 27.2; IR: 3333, 2950, 2868, 
1501, 1476, 1283, 1110, 1045, 736 cm
–1
; HRMS Calcd. for C11H22N3O [M+H]
+
: 
212.17629, Found: 212.17638. 
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(4S)-4-tert-Butyl-2-methoxy-3-((1-methyl-1H-imidazol-2-yl)methyl)oxazolidine 
(2.40) (85:15 dr). To a solution of (S)-3,3-dimethyl-2-(((1-methyl-1H-imidazol-2-
yl)methyl)amino)butan-1-ol (0.70 g, 3.3 mmol) in anhydrous methanol (13 mL) under 
argon was added N,N-dimethylformamide dimethyl acetal (0.40 mL, 3.3 mmol). The 
reaction was stirred at room temperature for 2 hours, and the solvent was removed under 
vacuum. The residue was redissolved in anhydrous methanol (13 mL), and the reaction 
was again stirred at room temperature for 2 hours until 
1
H NMR analysis showed all the 
substrate was consumed and product had formed. The solvent was removed under 
vacuum. The flask was brought into a dry glove box under nitrogen atmosphere, and the 
residue was extracted with degassed pentane. The pentane was removed under vacuum, 
and Kugelrohr distillation (180 °C @ 0.05 mm Hg) afforded the pure product as a 
colorless oil (190 mg, 23%). 
1
H NMR (C6D6, 500 MHz) δ 7.21 (s, 1H), 6.38 (s, 1H), 5.55 
(s, 0.85H), 5.28 (s, 0.15H), 3.95 (d, 1H, J = 13.4), 3.85-3.89 (m, 1H), 3.78-3.81 (m, 1H), 
3.65 (d, 1H, J = 13.4), 3.15 (s, 0.5H), 3.13 (s, 2.5H), 3.01 (s, 2.5H), 3.00 (s, 0.5H), 2.65-
2.68 (m, 1H), 0.85 (s, 1.4H), 0.83 (s, 7.6H); 
13
C NMR (CDCl3, 126 MHz) δ 145.2, 127.3, 
121.7, 120.9, 114.9, 111.0, 72.3, 68.8, 66.3, 65.1, 53.2, 52.5, 51.8, 38.1, 34.6, 33.5, 33.3, 
26.7, 26.4; IR: 2955, 2905, 1499, 1477, 1285, 1147, 1132, 1082, 1066, 993, 740 cm
–1
; 
HRMS Calcd. for C12H20N3O [M-OMe]: 222.1606, Found: 222.1612.  
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(S)-2-(((1-Methyl-1H-imidazol-2-yl)methyl)amino)-2-phenylethanol.
2
 To a solution of 
N-methyl-imidazole-2-carboxaldehyde (1.37 g, 10.0 mmol) in benzene (30 mL) was 
added (S)-Glycinol (1.10 g, 10.0 mmol) and 3Å molecular sieves (1.4 g). After refluxing 
for 24 hours, the reaction was cooled to room temperature and the solvent was removed 
in vacuo. The resulting residue was redissolved in MeOH (30 mL) and NaBH4 (378 mg, 
10.0 mmol) was added. The reaction was stirred at room temperature for 2 hours, 
followed by quenching with dropwise addition of concentrated HCl (0.51 mL). The 
resulting mixture was further neutralized with Na2CO3 (1.67 g). The precipitated salts 
were filtered off, and the filtrate was concentrated. Flash column chromatography 
(CH2Cl2:MeOH = 10:1) afforded the pure product as a yellow oil (1.88 g, 81%). 
1
H NMR 
(CDCl3, 500 MHz)  7.37-7.21 (m, 5H), 6.84 (d, 1H, J= 1.0), 6.72 (d, 1H, J= 1.0), 3.86-
3.82 (m, 1H), 3.69-3.66 (m, 3H), 3.55 (dd, 1H, J= 9.5, 11.0), 3.45 (s, 3H);
 13
C NMR 
(CDCl3, 125 MHz)  146.8, 140.8, 128.5, 127.6, 127.5, 126.8, 121.0, 66.9, 65.3, 55.9, 
43.3, 32.6; IR: 3299, 2914, 2842, 1493, 1283, 1050, 758, 702 cm
–1
; HRMS Calcd. for 
C13H18N3O [M+H]
+
: 232.1449, Found: 232.1454. 
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(4S)-2-Methoxy-3-((1-methyl-1H-imidazol-2-yl)methyl)-4-phenyloxazolidine (2.43) 
(60:40 dr). To a solution of (S)-2-(((1-methyl-1H-imidazol-2-yl)methyl)amino)-2-
phenylethanol (1.88 g, 8.1 mmol) in anhydrous methanol (30 mL) under argon was added 
N,N-dimethylformamide dimethyl acetal (1.09 mL, 8.1 mmol). The reaction was stirred at 
room temperature for 2 hours, and the solvent was removed under vacuum. The residue 
was redissolved in anhydrous methanol (13 mL), and the reaction was again stirred at 
room temperature for 1 hour until 
1
H NMR analysis showed all the substrate was 
consumed and product had formed. The solvent was removed under vacuum. The flask 
was brought into a dry glove box under nitrogen atmosphere, and the residue was 
extracted with degassed pentane to afford the pure product as a pale yellow oil (1.95 g, 
88%). 
1
H NMR (C6D6, 500 MHz) δ 7.26-7.24 (m, 1.2H), 7.18-7.15 (m, 0.8H), 7.09-6.99 
(m, 3H), 6.98 (d, 0.4H, J= 1.0), 6.96 (d, 0.6H, J= 1.0), 6.22 (d, 0.4H, J= 1.0), 6.20 (d, 
0.6H, J= 1.0), 5.60 (s, 0.6H), 5.39 (s, 0.4H), 4.18 (t, 0.6H, J= 8.0), 4.09 (t, 0.4H, J= 8.0), 
3.98-3.95 (m, 1H), 3.87 (dd, 0.6H, J= 7.0, 8.0), 3.72 (dd, 0.4H, J= 8.0, 9.5), 3.70-3.67 (m, 
0.8H), 3.70 (d, 0.6H, J= 14.0), 3.65 (d, 0.6H, J= 14.0), 3.20 (s, 0.4H), 3.15 (s, 0.6H), 2.77 
(s, 0.6H), 2.72 (s, 0.4H); 
13
C NMR (CDCl3, 126 MHz) δ 144.2, 143.9, 140.6, 138.9, 
128.2, 127.1, 120.5, 120.4, 113.1, 110.5, 109.1, 106.5, 73.2, 72.3, 66.0, 63.3, 52.7, 50.9, 
44.9, 44.0, 41.8, 37.5, 32.0, 31.6; IR: 2943, 1498, 1453, 1283, 1155, 1042, 731, 700 cm
–1
; 
HRMS Calcd. for C14H16N3O [M-OMe]: 242.1293, Found: 242.1308. 
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(S)-4-Methyl-2-(((1-methyl-1H-imidazol-2-yl)methyl)amino)pentan-1-ol.
2
 To a 
solution of N-methyl-imidazole-2-carboxaldehyde (1.65 g, 15.0 mmol) in benzene (30 
mL) was added (S)-Leucinol (1.17 g, 10.0 mmol) and 3Å molecular sieves (1.4 g). After 
refluxing for 24 hours, the reaction was cooled to room temperature and the solvent was 
removed in vacuo. The resulting residue was redissolved in MeOH (30 mL) and NaBH4 
(567 mg, 15.0 mmol) was added. The reaction was stirred at room temperature for 2 
hours, followed by quenching with dropwise addition of concentrated HCl (0.51 mL). 
The resulting mixture was further neutralized with Na2CO3 (1.67 g). The precipitated 
salts were filtered off, and the filtrate was concentrated. Flash column chromatography 
(CH2Cl2:MeOH = 10:1) afforded the pure product as a yellow oil (1.58 g, 75%). 
1
H NMR 
(CDCl3, 500 MHz)  6.80 (d, 1H, J= 1.0), 6.73 (d, 1H, J= 1.0), 3.84 (d, 1H, J= 14.5), 
3.76 (d, 1H, J= 14.5), 3.56 (s, 3H), 3.30-3.26 (m, 1H), 2.69-2.65 (m, 1H), 1.65-1.58 (m, 
1H), 1.31-1.25 (m, 1H), 1.19-1.14 (m, 1H), 0.817 (d, 3H, J= 6.5), 0.793 (d, 3H, J= 6.5);
 
13
C NMR (CDCl3, 125 MHz)  146.9, 126.6, 121.2, 63.1, 57.1, 42.6, 41.1, 32.6, 24.8, 
22.8, 22.7; IR: 3281, 2952, 2867, 1500, 1466, 1051, 735 cm
–1
; HRMS Calcd. for 
C11H22N3O [M+H]
+
: 212.1762, Found: 212.1761. 
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(4S)-4-Isobutyl-2-methoxy-3-((1-methyl-1H-imidazol-2-yl)methyl)oxazolidine (2.41) 
(75:25 dr). To a solution of (S)-4-methyl-2-(((1-methyl-1H-imidazol-2-
yl)methyl)amino)pentan-1-ol (0.70 g, 3.3 mmol) in anhydrous methanol (13 mL) under 
argon was added N,N-dimethylformamide dimethyl acetal (0.40 mL, 3.3 mmol). The 
reaction was stirred at room temperature for 2 hours, and the solvent was removed under 
vacuum. The residue was redissolved in anhydrous methanol (13 mL), and the reaction 
was again stirred at room temperature for 2 hours until 
1
H NMR analysis showed all the 
substrate was consumed and product had formed. The solvent was removed under 
vacuum. The flask was brought into a dry glove box under nitrogen atmosphere, and the 
residue was extracted with degassed pentane. The pentane was removed under vacuum, 
and Kugelrohr distillation (180 °C @ 0.05 mm Hg) afforded the pure product as a pale 
green oil (190 mg, 23%). 
1
H NMR (C6D6, 500 MHz) δ 7.12 (d, 0.25H, J= 1.0), 7.09 (d, 
0.75H, J= 1.0), 6.34 (d, 0.25H, J= 1.0), 6.32 (d, 0.75H, J= 1.0), 5.29 (s, 0.75H), 5.17 (s, 
0.25H, J= 1.0), 3.92-3.87 (m, 0.75H), 3.86-3.84 (m, 0.25H), 3.81-3.76 (m, 0.5H), 3.75 (d, 
0.75H, J= 13.5), 3.68 (d, 0.75H, J= 13.5), 3.55-3.49 (m, 0.75H), 3.44-3.40 (m, 0.25H), 
3.19 (s, 0.75H), 3.11 (s, 2.25H), 3.09-3.01 (m, 1H), 3.04 (s, 2.25H), 2.97 (s, 0.75H), 1.28-
1.15 (m, 2.25H), 1.11-1.05 (m, 0.75H), 0.748 (d, 0.75H, J= 6.5), 0.722 (d, 0.25H, J= 6.5), 
0.701 (d, 0.75H, J= 6.5), 0.674 (d, 0.25H, J= 6.5); 
13
C NMR (CDCl3, 126 MHz) δ 144.6, 
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126.7, 120.7, 114.0, 112.6, 110.6, 71.1, 70.9, 70.5, 70.1, 57.5, 56.1, 52.3, 50.8, 47.2, 42.6, 
42.1, 41.5, 37.5, 31.9, 25.5, 23.6, 23.5, 22.1, 21.7; IR: 2953, 1500, 1284, 1160, 1076, 
1036, 736 cm
–1
; HRMS Calcd. for C12H20N3O [M-OMe]: 222.1606, Found: 222.1611. 
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2-(((1-Methyl-1H-imidazol-2-yl)methyl)amino)ethanol.
2
 To a solution of N-methyl-
imidazole-2-carboxaldehyde (2.0 g, 18 mmol) in methanol (40 mL) was added 
ethanolamine (1.1 mL, 18 mmol) and 3Å molecular sieves (1.4 g). After refluxing for 24 
hours, the reaction was cooled to room temperature, and NaBH4 (1.0 g, 27 mmol) was 
added. The reaction was stirred at room temperature for 2 hours, followed by quenching 
with dropwise addition of concentrated HCl (0.88 mL). The resulting mixture was further 
neutralized with Na2CO3 (2.9 g). The precipitated salts were filtered off, and the filtrate 
was concentrated. Flash column chromatography (CH2Cl2:MeOH = 9:1) afforded the 
pure product as a yellow oil (1.9 g, 68%). 
1
H NMR (CDCl3, 500 MHz)  6.81 (d, 1H, J= 
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1.0), 6.74 (d, 1H, J= 1.0), 5.79 (s, 2H), 3.89 (s, 2H), 3.62 (t, 2H, J= 5.0), 3.58 (s, 3H), 
2.82 (t, 2H, J= 5.0);
 13
C NMR (CDCl3, 125 MHz)  144.7, 126.8, 121.6, 59.5, 50.8, 43.8, 
32.9; IR: 3280, 2947, 1496, 1282, 1049, 748, 655 cm
–1
; HRMS Calcd. for C7H14N3O 
[M+H]
+
: 156.1136, Found: 156.1141. 
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2-Methoxy-3-((1-methyl-1H-imidazol-2-yl)methyl)oxazolidine (2.20). To a solution of 
2-(((1-methyl-1H-imidazol-2-yl)methyl)amino)ethanol (0.50 g, 3.2 mmol) in anhydrous 
methanol (11 mL) under argon was added N,N-dimethylformamide dimethyl acetal (0.51 
mL, 3.8 mmol). The reaction was stirred at room temperature for 2 hours, and the solvent 
was removed under vacuum. The residue was redissolved in anhydrous methanol (11 
mL), and the reaction was again stirred at room temperature for 2 hours until 
1
H NMR 
analysis showed all the substrate was consumed and product had formed. The solvent was 
removed under vacuum. The flask was brought into a dry glove box under nitrogen 
atmosphere, and the residue was extracted with degassed pentane to afford the pure 
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product as a colorless oil (324 mg, 51%). 
1
H NMR (C6D6, 500 MHz) δ 7.05 (d, 1H, J= 
1.0), 6.38 (d, 1H, J= 1.0), 5.09 (s, 1H), 3.74 (d, 1H, J= 13.0), 3.65 (d, 1H, J= 13.0), 3.67-
3.63 (m, 1H), 3.57-3.53 (m, 1H), 3.09 (s, 3H), 2.99 (s, 3H), 2.77-2.73 (m, 1H), 2.60-2.56 
(m, 1H); 
13
C NMR (CDCl3, 126 MHz) δ 144.6, 120.9, 111.6, 107.1, 64.8, 51.1, 49.1, 
46.1, 37.6; IR: 2948, 2894, 1500, 1284, 1046, 953, 736 cm
–1
; HRMS Calcd. for 
C8H12N3O [M-OMe]: 166.0980, Found: 166.0980. 
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(S)-3-Methyl-2-(((R)-(1-methyl-1H-imidazol-2-yl)(phenyl)methyl)amino)butan-1-ol.
2
 
To a solution of benzaldehyde (2.0 mL, 20.0 mmol) in benzene (30 mL) was added (S)-
Valinol (2.0 g, 20.0 mmol) and 3Å molecular sieves (1.4 g). After refluxing for 24 hours, 
the reaction was cooled to room temperature and the solvent was removed in vacuo. 
1
H 
NMR analysis showed that the imine had formed. The resulting residue was redissolved 
in diethyl ether (20 mL). In another oven-dried glass reaction flask, to the solution of N-
methylimidazole (5.6 mL, 70 mmol) in anhydrous diethyl ether (50 mL) under nitrogen 
atmosphere was added n-butyllithium (7.0 mL, 10 M in hexanes, 70 mmol) dropwise at –
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78 °C. The solution was stirred at –78 °C for 30 minutes, and then slowly cannula 
transferred into the solution of pre-formed imine at –78 °C. The resulting mixture was 
stirred at –78 °C for 2 hours and then at room temperature overnight. Aqueous NH4Cl 
was added slowly to quench the reaction. The organic layer was separated, and the 
aqueous layer was extracted with diethyl ether (3×50 mL). The combined organic layers 
were dried over MgSO4, filtered and concentrated. Flash column chromatography (3:1 
Hex/EtOAc to 100% EtOAc) afforded pure product as a yellow oil (3.8 g, 70%). 
1
H 
NMR (CDCl3, 500 MHz)  7.28-7.14 (m, 5H), 6.97 (d, 1H, J= 1.0), 6.77 (d, 1H, J= 1.0), 
4.91 (s, 1H), 3.63 (dd, 1H, J= 3.5, 11.0), 3.40 (dd, 1H, J= 8.0, 11.0), 3.26 (s, 3H), 2.53-
2.49 (m, 1H), 1.71-1.67 (m, 1H), 0.96 (d, 3H, J= 6.5), 0.90 (d, 3H, J=6.5);
 13
C NMR 
(CDCl3, 125 MHz)  149.3, 140.8, 128.9, 127.8, 127.6, 126.5, 121.6, 63.7, 62.9, 59.4, 
32.6, 31.7, 19.3; IR: 3339, 2955, 2870, 1492, 1281, 1048, 700 cm
–1
; HRMS Calcd. for 
C16H24N3O [M+H]
+
: 274.1919, Found: 274.1925.  
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(4S)-4-Isopropyl-2-methoxy-3-((R)-(1-methyl-1H-imidazol-2-yl)(phenyl)methyl)-
oxazolidine (2.45) (56:44 dr). To a solution of (S)-3-methyl-2-(((R)-(1-methyl-1H-
imidazol-2-yl)(phe nyl)methyl)amino)butan-1-ol (1.0 g, 4.0 mmol) in anhydrous 
methanol (16 mL) under nitrogen atmosphere was added N,N-dimethylformamide 
dimethyl acetal (0.53 mL, 4.0 mmol). The reaction was stirred at 50 °C overnight, 
concentrated, redissolved in MeOH (16 mL), and stirred for 2 hours, at which time 
1
H 
NMR analysis showed complete conversion to product. The solvent was removed under 
vacuum and extraction with degassed pentanes afforded the product as an orange oil (820 
mg, 65%). 
1
H NMR (CDCl3, 500 MHz)  7.96-7.66 (m, 1.12H), 7.47-7.44 (m, 0.88H), 
7.12-6.92 (m, 3H), 6.29 (d, 0.44H, J= 1.5), 6.22 (s, 0.56H), 6.19 (d, 0.56H, J= 1.5), 5.88 
(s, 0.44H), 5.17 (s, 0.44H), 5.01 (s, 0.56H), 4.00 (t, 0.56H, J= 8.0), 3.90 (t, 0.44H, J= 
8.0), 3.15-3.10 (m, 0.44H), 3.08-3.05 (m, 0.56H), 3.01 (s, 1.32H), 2.86 (s, 1.68H), 2.82 
(s, 1.68H), 2.74 (s, 1.32H), 1.77-1.70 (m, 1H), 0.91 (d, 1.68H, J= 7.0), 0.81 (d, 1.32H, J= 
6.5), 0.75 (d, 1.32H, J= 6.5), 0.37 (d, 1.68H, J=7.0);
 13
C NMR (CDCl3, 125 MHz)  
147.9, 146.4, 140.4, 139.2, 129.5, 129.4, 129.3, 120.6, 119.6, 119.5, 112.4, 111.7, 66.7, 
65.3, 64.3, 63.9, 59.6, 59.3, 52.3, 51.1, 31.6, 31.5, 30.5, 29.5, 29.4, 29.3, 19.5, 19.2, 19.1, 
17.2, 14.3, 14.2; IR: 2953, 1490, 1279, 1157, 1055, 962, 700 cm
–1
; HRMS Calcd. for 
C17H22N3O [M-OMe]: 284.1762, Found: 284.1748. 
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(S)-3-Methyl-2-(((R)-1-(1-methyl-1H-imidazol-2-yl)ethyl)amino)butan-1-ol.
2
 To a 
stirring solution of (S)-Valinol (2.0 g, 20 mmol) in anhydrous diethyl ether (10 mL) under 
nitrogen atmosphere was added a solution of acetaldehyde (1.1 mL, 20 mmol) in 
anhydrous diethyl ether (10 mL). MgSO4 (4.0 g) was added, and the solution was stirred 
at room temperature for 1 hour. 
1
H NMR analysis showed that the imine had formed. 
Solvent was pumped off and residue was redissolved in anhydrous diethyl ether (20 mL). 
In another oven-dried glass reaction flask, to the solution of N-methylimidazole (5.6 mL, 
70 mmol) in anhydrous diethyl ether (50 mL) under nitrogen atmosphere was added n-
butyllithium (7.0 mL, 10 M in hexanes, 70 mmol) dropwise at –78 °C. The solution was 
stirred at –78 °C for 30 minutes, and then slowly cannula transferred into the solution of 
pre-formed imine at –78 °C. The resulting mixture was stirred at –78 °C for 2 hours and 
then at room temperature overnight. Aqueous NH4Cl was added slowly to quench the 
reaction. The organic layer was separated, and the aqueous layer was extracted with 
diethyl ether (3×50 mL). The combined organic layers were dried over MgSO4, filtered 
and concentrated. Flash column chromatography (3:1 Hex/EtOAc to 100% EtOAc) 
afforded pure product as a yellow oil (971 mg, 23%). 
1
H NMR (CDCl3, 500 MHz)  6.84 
(d, 1H, J= 1.2), 6.72 (d, 1H, J= 1.2), 3.9 (q, 1H, J= 7.0), 3.55 (s, 3H), 3.47 (dd, 1H, J= 
3.5, 11.0), 3.30 (dd, 1H, J= 8.5, 11.0), 2.29-2.25 (m, 1H), 1.61-1.56 (m, 1H), 1.31 (d, 3H, 
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J= 7.0), 0.87 (d, 3H, J= 6.5), 0.87 (d, 3H, J= 6.5);
 13
C NMR (CDCl3, 125 MHz)  151.7, 
126.5, 121.2, 63.3, 62.8, 49.9, 32.5, 31.4, 21.6, 19.2, 19.1; IR: 3234, 2957, 1492, 1281, 
1121, 1052, 725 cm
–1
; HRMS Calcd. for C11H22N3O [M+H]
+
: 212.1762, Found: 
212.1764. 
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(4S)-4-Isopropyl-2-methoxy-3-((R)-1-(1-methyl-1H-imidazol-2-yl)ethyl)oxazolidine 
(2.46) (90:10 dr). To a solution of (S)-3-methyl-2-(((R)-1-(1-methyl-1H-imidazol-2-
yl)ethyl)amino)butan-1-ol (902 mg, 4.3 mmol) in anhydrous methanol (17 mL) under 
nitrogen atmosphere was added N,N-dimethylformamide dimethyl acetal (0.57 mL, 4.3 
mmol). The reaction was stirred at room temperature for 2 hours, and the solvent was 
removed under vacuum. The residue was redissolved in anhydrous methanol (17 mL), 
and another 0.5 equivalence of N,N-dimethylformamide dimethyl acetal was added to the 
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mixture. The reaction was again stirred at room temperature for 2 hours until 
1
H NMR 
analysis showed all the substrate was consumed and product had formed. The solvent was 
removed under vacuum. The flask was brought into a dry glove box under nitrogen 
atmosphere, and the residue was extracted with degassed pentanes to afford the pure 
product as a yellow oil (380 mg, 35%).  
1
H NMR (CDCl3, 500 MHz)  7.04 (d, 0.1H, J= 
1.5), 7.02 (d, 0.9H, J= 1.0), 6.33 (d, 0.1H, J= 1.5), 6.31 (d, 0.9H, J= 1.0), 5.53 (s, 0.1H), 
5.33 (s, 0.9H), 3.97 (q, 0.1H, J= 6.5), 3.88 (q, 0.9H, J= 6.5), 3.72-3.64 (m, 1.8H), 3.62-
3.56 (m, 0.2H), 3.13 (s, 2.7H), 3.10-3.08 (m, 1H), 3.09 (s, 2.7H), 2.95 (s, 0.3H), 2.84 (s, 
0.3H), 1.83 (d, 0.3H, J= 6.5), 1.51 (d, 2.7H, J= 6.5), 1.43-1.36 (m, 1H), 0.586 (d, 2.7H, 
J= 7.0), 0.559 (d, 0.3H, J= 7.0), 0.412 (d, 2.7H, J= 7.0), 0.380 (d, 0.3H, J= 7.0);
 13
C 
NMR (CDCl3, 125 MHz)  147.7, 126.9, 120.4, 114.3, 112.0, 107.7. 67.6, 67.0, 61.2, 
60.1, 52.2, 51.7, 50.4, 48.7, 46.0, 38.2, 31.4, 30.8, 30.4, 28.7, 19.0, 18.7, 17.1, 15.6, 13.5, 
11.3; IR: 2954, 1496, 1281, 1153, 1068, 970, 728 cm
–1
; HRMS Calcd. for C12H20N3O 
[M-OMe]: 222.1606, Found: 222.1615. 
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(S)-3-Methyl-2-(((S)-1-(1-methyl-1H-imidazol-2-yl)ethyl)amino)butan-1-ol.
2
 To a 
solution of N-methyl-imidazole-2-carboxaldehyde (3.42 g, 31.0 mmol) in benzene (90 
mL) was added (S)-Valinol (3.20 g, 10.0 mmol) and 3Å molecular sieves (1.4 g). After 
refluxing for 24 hours, the reaction was cooled to room temperature and the solvent was 
removed in vacuo. The resulting residue was redissolved in anhydrous diethyl ether (180 
mL). The solution was cooled to -78 
o
C and MeLi (31 mL, 3.0M in dimethoxyethane, 93 
mmol) was added dropwise. The reaction was allowed to stir for 24 hours before 
quenching with aqueous NH4Cl. The organic layer was separated, and the aqueous layer 
was extracted with ethyl acetate (3×100 mL). The combined organic layers were dried 
over MgSO4, filtered and concentrated. Flash column chromatography (CH2Cl2:MeOH = 
10:1) afforded pure product as a yellow oil (2.5 g, 38%). 
1
H NMR (CDCl3, 500 MHz)  
6.84 (d, 1H, J= 1.5), 6.70 (d, 1H, J= 1.5), 4.04 (q, 1H, J= 6.5), 3.63 (s, 3H), 3.55-3.52 (m, 
1H), 3.31 (dd, 1H, J= 6.5, 11.0), 2.25-2.22 (m, 1H), 1.65-1.61 (m, 1H), 1.36 (d, 3H, J= 
6.5), 0.845 (d, 3H, J= 7.0), 0.777 (d, 3H, J= 7.0);
 13
C NMR (CDCl3, 125 MHz)  150.8, 
126.8, 120.9, 62.2, 60.7, 47.9, 32.7, 29.3, 21.4, 19.4, 18.8; IR: 3311, 2956, 1467, 1280, 
1049, 725 cm
–1
; HRMS Calcd. for C11H22N3O [M+H]
+
: 212.1762, Found: 212.1769. 
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(4S)-4-Isopropyl-2-methoxy-3-((S)-1-(1-methyl-1H-imidazol-2-yl)ethyl)oxazolidine 
(2.47) (99:1 dr). To a solution of (S)-3-methyl-2-(((S)-1-(1-methyl-1H-imidazol-2-
yl)ethyl)amino)butan-1-ol (4.3 g, 18 mmol) in anhydrous methanol (36 mL) under 
nitrogen atmosphere was added N,N-dimethylformamide dimethyl acetal (12 mL, 90 
mmol). The reaction was stirred at 50 °C overnight, concentrated, redissolved in 
methanol, and stirred for 2 hours, at which time, 
1
H NMR analysis showed complete 
conversion to product. The solvent was removed under vacuum, and Kugelrohr 
distillation (130 °C @ 0.05 mm Hg) afforded the product as a colorless oil (3.7 g, 73%). 
1
H NMR (CDCl3, 500 MHz)  7.04 (d, 1H, J= 1.5), 6.35 (d, 1H, J= 1.5), 5.52 (s, 1H), 
3.75-3.64 (m, 3H), 3.11 (s, 3H), 2.85-2.81 (m, 1H), 2.83 (s, 3H), 1.66-1.59 (m, 1H), 1.55 
(d, 3H, J= 7.0), 0.77 (d, 3H, J= 7.0), 0.75 (d, 3H, J= 7.0);
 13
C NMR (CDCl3, 125 MHz)  
148.0, 126.9, 120.8, 111.5, 66.9, 65.1, 51.8, 51.2, 32.0, 30.9, 19.9, 17.6, 13.5; IR: 2954, 
1281, 1155, 1056, 971, 728 cm
–1
; HRMS Calcd. for C12H20N3O [M-OMe]: 222.1606, 
Found: 222.1615.  
 
 
 
180 
 
 
 
 
181 
 
 
(S)-3-Methyl-2-((R)-2-methyl-1-(1-methyl-1H-imidazol-2-yl)propylamino)butan-1-
ol.
2
 To a stirring solution of (S)-Valinol (6.8 g, 66 mmol) in anhydrous diethyl ether (66 
mL) under nitrogen atmosphere was added a solution of isobutyraldehyde (4.8 g, 66 
mmol) in anhydrous diethyl ether (66 mL). MgSO4 (13 g) was added, and solution was 
stirred at room temperature overnight. 
1
H NMR analysis showed that the imine had 
formed. In another oven-dried glass reaction flask, to the solution of N-methylimidazole 
(19 g, 230 mmol) in anhydrous THF (160 mL) under nitrogen atmosphere was added n-
butyllithium (23 mL, 10 M in hexanes, 230 mmol) dropwise at –78 °C. The solution was 
stirred at –78 °C for 30 minutes, and then slowly cannula transferred into the solution of 
pre-formed imine at –78 °C. The resulting mixture was stirred at –78 °C for 2 hours and 
then at room temperature overnight. Aqueous NH4Cl was added slowly to quench the 
reaction. The organic layer was separated, and the aqueous layer was extracted with 
diethyl ether (3×100 mL). The combined organic layers were dried over MgSO4, filtered 
and concentrated. Flash column chromatography (2:1 Hex/EtOAc to 100% EtOAc) 
afforded pure product as colorless oil (12 g, 76%). 
1
H NMR (CDCl3, 500 MHz)  6.93 (d, 
1H, J = 1.2), 6.78 (d, 1H, J = 1.2), 3.56 (m, 4H), 3.35 (d, 1H, J = 1.2), 3.34 (d, 1H, J = 
3.9), 2.15 (m, 1H), 1.90 (m, 1H), 1.64 (m, 1H), 0.98 (d, 3H, J = 6.8), 0.93 (d, 3H, J = 
6.8), 0.88 (d, 3H, J = 2.9), 0.87 (d, 3H, J = 2.9);
 13
C NMR (CDCl3, 125 MHz)  151.7, 
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127.0, 121.3, 64.2, 62.9, 60.4, 34.0, 32.9, 31.7, 20.2, 19.5, 19.4, 17.7; IR: 2956, 2871, 
1488, 1468, 1280, 1045, 725 cm
–1
; HRMS Calcd. for C13H26N3O [M+H]
+
: 240.2076, 
Found: 240.2087.  
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(4S)-4-Isopropyl-2-methoxy-3-((R)-2-methyl-1-(1-methyl-1H-imidazol-2-yl)propyl)-
oxazolidine (2.48) (99:1 dr). To a solution of (S)-3-methyl-2-(((R)-2-methyl-1-(1-
methyl-1H-imidazol-2-yl)propyl)amino)butan-1-ol (4.3 g, 18 mmol) in anhydrous 
methanol (36 mL) under nitrogen atmosphere was added N,N-dimethylformamide 
dimethyl acetal (12 mL, 90 mmol). The reaction was stirred at 50 °C overnight, 
concentrated, redissolved in methanol, and stirred for 2 hours, at which time, 
1
H NMR 
analysis showed complete conversion to product. The solvent was removed under 
vacuum, and Kugelrohr distillation (130 °C @ 0.05 mm Hg) afforded the product as a 
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colorless oil (3.7 g, 73%). 
1
H NMR (CDCl3, 500 MHz)  7.12 (d, 1H, J = 1.2), 6.80 (s, 
1H), 6.20 (d, 1H, J = 1.2), 3.70 (dd, 1H, J = 9.0, 8.1), 3.52 (dd, 1H, J = 7.8, 7.1), 3.29 (s, 
3H), 3.22 (d, 1H, J = 10.8), 2.78 (s, 3H), 2.60 (m, 2H), 1.68 (m, 1H), 1.34 (d, 3H, J = 
6.4), 0.85 (d, 3H, J = 6.8), 0.66 (d, 3H, J = 6.8), 0.63 (d, 3H, J = 6.6);
 13
C NMR (CDCl3, 
125 MHz)  148.8, 128.7, 120.1, 112.4, 66.1, 65.8, 60.5, 52.7, 33.7, 32.2, 29.5, 21.6, 
21.0, 20.2, 16.9; IR: 2956, 1470, 1281, 1052, 964 cm
–1
; HRMS Calcd. for C14H24N3O 
[M-OMe]: 250.1919, Found: 250.1926. 
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